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ABSTRACT
O P T IM IZ A T IO N OF CRYOPRESERVATION
PROTOCOLS FOR CARDIOVASCULAR TISSUE
Jianfei Hu
Old Dominion University
and
Eastern Virginia Medical School
Director: Dr. Lloyd Wolfinbarger, Jr.

The purpose of this research was to determine the effects of cryopreservation on
the physical, biochemical and cellular aspects of heart valve tissue.
The present study demonstrated that radiolabeled proline accumulation provides
a quantitative estimate of total cellular metabolic viability.

Radiolabeled inulin was

demonstrated to be a useful marker for extracellular tissue space.
Assessment of metabolic viability of the cellular population of leaflet tissue as a
function of procurement and processing revealed that proline accumulation declined with
increasing warm and cold ischemic times. Amphotericin B and streptomycin were toxic
to the cells.

Cefoxitin, lincomycin, polymyxin B, vancomycin and penicillin had no

apparent effect on viability of cells in heart valve tissue. The study also revealed that
antibiotic solution (amphotericin B, cefoxitin, polymyxin B, lincomycin, vancomycin)
utilized to disinfect tissue

was able to kill E. coli, S. aureus, S. epidermidis, S.
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pneumoniae, C. peifiingens, but not S. faecalis after these bacteria were incubated with
antibiotic solution for 24 or 48 hrs at 4°C. The cryoprotectants, dimethyl sulfoxide and
glycerol were shown to reduce cellular metabolic viability when heart valve leaflets were
incubated in RPM I 1640 medium supplemented with 10% fetal calf serum and either
10% Me SO or 15% glycerol over 180 minutes at both 4°C and 37°C. Incubation of
2

tissue for 10 minutes in concentrations of MejSO and glycerol greater than 5% resulted
in a significant reduction in proline accumulation at both 4°C and 37°C. The results
revealed that penetration rates of both MejSO and glycerol at 37°C were faster than at
4°C.

After step-wise dilution to remove the cryoprotectants, there was still 0.25 M

Me SO and 0.2 M glycerol in the porcine aortic conduit tissue, respectively. The results
2

demonstrated that cryopreserved human heart valve tissue, plunged into liquid nitrogen
for as little as 5 minutes, appears to have numerous microffactures over the surfaces of
the tissue, penetrating into the collagen / proteoglycan matrix. Thawing at 37°C and
42°C resulted in low percentage of nonviable cells, whereas thawing at 4°C, 20°C, or
75°C resulted in much higher percentage of nonviable cells.
Assessment of the tendency of heart valve tissue to "calcify" was performed by
measuring the ability of the tissue to induce alkaline phosphatase activities in fibroblast
cell cultures.

Porcine heart valve tissue with prolonged warm ischemic time, cold

ischemic time and amphotericin B treatment induced significantly higher alkaline
phosphatase activities than fresh porcine heart valve tissue.
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INTRODUCTION

The history of using allograft heart valves and greater vessel valve-containing
conduits in the repair of ventricular outflow tract defects, mitral valve disease, and aortic
regurgitation dates back more than 30 years. Lam (Lam et al., 1952) reported in 1952
that it was technically possible to transplant canine aortic valve allografts into the
descending aorta of a recipient animal and this animal study became the basis for work
by other investigators who used the concept in different and more successful ways.
Gordon Murray’s pioneering work reported in 1956, demonstrated that allograft aortic
valve segments could be transplanted into not only the descending aorta but also the
mitral position (Murray et al., 1956).

It was not until 1962, however, that the aortic allograft was inserted in the native
or subcoronary position of the heart.

Donald Ross first performed this procedure

utilizing a single running suture line technique at Guy’s hospital in London on July 24,
1962 (Ross, 1962) with technical help from Gunning and Duran (Duran and Gunning,
1962) of Oxford University. Barratt-Boyes at the Green Lane Hospital in New Zealand
independently developed the same concept for subcoronary replacement of the allograft
aortic valve and began performing it clinically in August, 1962 (Barratt-Boyes, 1965).

1
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To place the use of allograft valves into proper perspective, a brief review of
available alternatives is essential. An ideal valve substitute should be nonthrombogenic
so that anticoagulation therapy w ill not be required and emboli w ill not develop. The
substitutes should also have good hemodynamics, without causing hemolysis, they should
be readily available in a wide variety of sizes and be easy to implant. The available
alternatives include a variety of mechanical valve substitutes, porcine and bovine
pericardial bioprosthetic valves.

The first mechanical substitute for a human heart valve was the Starr-Edwards
ball valve (Baxter Edwards laboratories, Santa Anna, CA) which was first implanted in
the 1960s (MacManus et al., 1977). The cage design of the ball valve went through a
number of changes from where the cage was open or closed, the struts were either
covered or uncovered, and their numbers were varied. In addition, various materials,
primarily stronger alloys, were used to construct the cage. The poppet forming the
closure mechanism of the valve was an engineering challenge for biocompatibility. Ball
variance, resulting from adsorption of lipids and water, led to serious complications such
as cracks, fragmentation, swelling, and sticking of the prosthesis. Striking improvements
were a special curing process for the silicone elastomer (silastic) rubber and a convex
design of the poppet seat that allowed for better closure characteristics (Cobanoglu and
Starr, 1987). The current Starr-Edwards models for mitral and aortic valves have been
in use since 1965 and 1968, respectively, and serve as the standard of comparison for

2
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all mechanical valves. There has never been a strut fracture or a ball escape in either
o f these designs.

The major problems with the mechanical prostheses have been their
thrombogenicity and the related problems associated with required anticoagulation
therapy. Starr (Starr et a l., 1988) reported a nearly linear incidence of thromboembolism
(3.3% per patient-year) over 20 years in a series of 707 patients with prosthetic aortic
valves. Anticoagulant-related hemorrhage occured almost as often at 2.5% per patientyear. Prosthetic valve endocarditis was reported at 0.9% per patient-year. The 10-year
survival of Starr-Edwards valves was reported at 56% (Penta et al., 1984).

With recognition of the limitations of the mechanical devices used to replace
cardiac valves, it is understandable that various tissue valves or bioprosthetic substitutes
have been tried. Bioprosthetic valves involve a glutaraldehyde fixation process and
allow biologic heart valve tissue to serve as a human valve substitute. The mainstay of
bioprosthetic valves since 1970, has been theglutaraldehyde-fixed porcine cardiac valves
(Magilligan, 1987). The major advantage of tissue valves over mechanical valves was
the marked reduction of thromboembolic complications with long-lasting hemodynamic
function and the avoidance of anticoagulant use with their attendant bleeding difficulties.
However, the most prominent complication of an implanted porcine bioprosthesis was
primary tissue failure. This structual deterioration dramatically influenced long-term
durability. Primary tissue failure is defined to be valve incompetence or stenosis with

3
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degenerative changes confirmed on gross and histologic examinations of explanted valves
without any clinical, bacteriologic, or histologic evidence of infection (Magilligan, 1987).
Crayer and associates in 1982 reported a highly significant increase in the incidence of
graft failure at six years in more than 1000 patients evaluated (Craver et al., 1982). This
group also noted that the failure rate was greater in patients younger than 35 years than
in those older than 35 years. They recognized , however, that primary tissue failure in
general was a slow process that allowed for detection, investigation and elective
reoperation without a marked increase in operative mortality for the secondary procedure.
With time, further evaluation was possible and Jamieson and associates reported in
1988, following an evaluation of 1,183 patients followed for a mean of 4.6 years after
implantation of the Carpentier-Edwards bioprosthesis (Jamieson et al., 1988), that the
mean implant time of failed valves was 74 months. A 10- to 15- year follow-up study
of the Hancock mitral valve,

reported by Foster and associates, demonstrated the

nonlinearity of the failure rate. The average time to failure was almost 9 years (Foster
et al., 1987). In the aortic position, primary tissue failure also occured despite good
early results. At 6 years, 97% of valves were free of this complication but at 12.5
years only 68% of patients older than 40 years of age were free of tissue failure (Gallo,
1988). The major cause of valve failure was calcification of the porcine bioprosthetic
valves. This observation was especially true in young patients. Geha and colleagues
(Geha et al., 1979) described 25 patients who had valve replacement between the ages
of 17 months and 16 years. Twenty percent of them (5 patients) required re-replacement
within 18 to 45 months.

Silver and co-workers (Silver et al., 1980) described

4
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calcification of porcine bioprostheses, reporting that it usually

began near the

commissures of the valve leaflets. These investigators thought that a positive calcium
balance with a more labile calcium homeostasis was the contributing factor to premature
calcification.

Various attempts to reduce rates of calcification and improve the durability of the
porcine bioprosthesis have been undertaken.

Carpentier reported that chemical

treatments, namely those with HEPES buffer, magnesium chloride, or a surfactant
(Tween 80), when combined with glutaraldehyde fixation could decrease the incidence
of calcification (Carpentier et al., 1984). Agents such as N-Laurylsarcosine and Triton
X-100 were found to be most efficient, presumably by inhibiting phospholipid penetration
into the tissue as a preliminary step in the calcification process.

In summary, in spite of failing to meet early expectations, the porcine xenograft
valve has proven to be a satisfactory valve alternative for many older patients and for
others in whom it is desirable to avoid anticoagulation therapy.

With failure

of

porcine heterografts being reported, investigators sought

alternative tissue substitutes with the hope of finding a more durable device. A valve
substitute made of bovine pericardium, carefully treated with glutaraldehyde and
fashioned into a trileafleted valve, has been used clinically by Marion Ionescu since 1971
(Crawford, 1987). Early results with this valve have been approximately the same as for

5
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porcine valves, but the hemodynamics have been somewhat better in the smaller sizes.
Problems, however, include abrasion of the leaflets against the cloth of the sewing ring,
producing additional modes of failure. Accelerated failure with the bovine tissue valves
also occurs in children, as was reported with the porcine heterografts. Primary tissue
failure occurs with these valves and it appears that collagen bundle disruption preceeds
cusp rupture (Daenen et al., 1988). Reul and associates at the Texas Heart Institute
studied a series of 2,680 patients with bovine pericardial bioprostheses between 1978 and
1983 and reported the actuarial freedom from reoperation at 5 years was 82% for
patients with aortic valve replacement and 87% for patients with mitral valve replacement
(Reul et al., 1985). However, calcification and leaflet disruption intensified between 4
and 5 years after surgery. Failure was more likely when the valves were of small size
or were in the aortic position and when patients were younger than 30 years of age.

In view of the problems with mechanical and bioprosthetic valves, the search for
a perfect substitute goes on. Rahimtoola concluded that no prosthetic valve yet developed
approaches the normal human valve in either hemodynamic function or freedom from
complications (Rahimtoola, 1978).

Despite the ready availability of mechanical and bioprosthetic valves it is
understandable that researchers turned to the allograft valve. It was generally accepted
that it would be difficult to improve on the design characteristics of the human aortic
valve (Ross, 1965). The normal heart valve provides no obstructive gradient at rest or

6
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with exercise and provides blood flow with minimal turbulence during left ventricular
ejection. It also has an absolutely regurgitation-free closure mechanism due to the design
of the sinuses of Valsalva.

Allograft valve replacement in the aortic position began with the historic work
of Ross (1962) and Barratt-Boyes (1965). Patients with the entire spectrum of aortic
valve disorders including congenital, rheumatic, infectious and degenerative diseases have
been treated with allograft valve replacement.

The advantages of the aortic valve

allograft have included its remarkable hemodynamic function and

freedom from

thromboembolism. Barratt-Boyes reported an absence of a significant pressure gradient
in over 2000 aortic valve replacements with allografts (1979) and Ross had only one
patient with an episode of thromboembolism in 2931 patient-years follow-up (Matsuki et
al., 1988). Anticoagulant therapy is not routinely used in patients receiving allografts
(Gonzalez-Lavin and Ross, 1970) and allograft valves have consistly shown early
resistance to the development of endocarditis (O’Brien et al., 1987).

Although the allograft is superior to the mechanical and bioprosthetic valves in
almost every aspect, there are several obstacles to overcome with its use. One major
problem is limited availability and short "shelf life",

second problem is valvular

incompetence. The development of cryopreservation is now permitting long term storage
of the allograft heart valve and

improving on availability.

It has also

7
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allowed

procurement of quality tissue at sites and times remote from implantation both in distance
and in time.

The basic concepts of allograft valve cryopreservation were initially reported by
Donald Ross in 1972 who freeze-dried, or rapidly froze sheep valves in dimethyl
sulfoxide (N ^SO ) (Savage et al., 1972).

Mark O’Brien in Australia developed a

standardized technique of valve cryopreservation which involved controlled-rate freezing
after short-term antibiotic sterilization (O’Brien et al., 1987).

These preservation

techniques made the long-term storage of vital heart valves possible and available on a
widespread basis. The O’Brien technique was adopted by Kirklin in the United States
in 1981 (Kirklin et al., 1987) and was further developed by LifeNet-Virginia Tissue Bank
and a commercial cryopreservation center (Cryolife) for the processing and nation-wide
redistribution of allograft cardiac valves (McNally et al., 1988).

These programs made

availability of high-quality allograft tissue in the United States a reality.

The cryopreservation process includes, procurement and transport, antibiotic
disinfection, cryopreservation, storage, and thawing with removal of cryoprotectants
followed by eventual transplantation of the allograft valves.

The duration of warm ischemic time and cold ischemic time experienced during
procurement and transportation of the tissue has been shown to be very important in
valve survival.

Penta reported that prolonged warm ischemic time at procurement

8
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(interval between cessation of donor heart beat to. initial cooling of valve tissue with cold
saline) was correlated with increased risk for valve degeneration (Penta et al., 1984).
Kirklin and O’Brien attempted to limit the warm ischemic time as much as possible
(Kirklin et al., 1987; O’Brien et al., 1988).

Cold ischemic time is associated with

transport of valve tissue from the site of procurement to the site of processing. Cold
ischemic time is defined as the time interval after transfer of the heart to cold transport
solutions until the subsequent processing. Transport media (e.g. UW solution) utilizing
adenosine and enriched with metabolic phosphates may preserve cellular viability
(Sommer e ta l., 1988).

Obtaining human tissue in a timely fashion without risking microbial
contamination or transmission of other infectious diseases is also a major concern. The
problem of allograft valve sterility at the time of procurement was documented in Yacoub
and Kittle’s classic study in which blood taken under sterile conditions and cultured from
the hearts of 45 cadavers, 6 to 48 hours after death, grew bacteria in 85% of the cases
(Yacoub and Kittle, 1970). Gonzalez-Lavin et al., (1988a) found that nine of seventeen
(53%) homovital (valves obtained under sterile conditions from brain-dead, multi-organ
donors) aortic and pulmonary valves conduits yielded positive cultures at the time of
dissection from the donor heart.

Contaminating organisms included Anaerobic

diptheroids, Staphylococcus aureus, and Propionibacterium.

The initial method of

sterilization of allograft heart valves included use of ethylene oxide (Longmore et al.,
1966), beta-propriolactone (Rains et al., 1956), formalin and gamma irradiation with or

9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

without flash freezing, and freeze drying. Although effective, these methods resulted in
unacceptable levels of valve failure. Hudson (Hudson, 1966) studied freeze dried valves
sterilized by the ethylene oxide technique and reported that the cusps remained acellular
and often tore or ruptured after implantation. The same observation was reported by
groups studying freeze dried valves sterilized by the beta-priopriolactone method ( Smith,
1967). Missen and Roberts (Missen and Roberts, 1970) also reported that calcification
and cusp rupture occurred in

freeze dried valves sterilized by the ethylene oxide

technique and the beta-propriolactone method. Barratt-Boyes first suggested the use of
antibiotics for sterilization of heart valves used in clinical practice (Barratt-Boyes, 1965).
A variety of antibiotic formulae have been utilized (Armiger et al., 1983; Lockey et al.,
1972 and Strickett et

al., 1983). Hu (Hu et al., 1989) demonstrated that heart valves

sterilized with either penicillin or lincomycin, polymyxcin B, cefoxitin, and vancomycin
contained viable fibroblasts after as long as 24 to 48 hrs of disinfection.

A basic principle of cryobiology is that the extent of freezing damage depends on
the amount of free water in the system and the ability of that water to undergo
crystallization (Bank and Brockbank, 1987).

Factors affecting the success of

cryopreservation of tissues include tissue mass and geometry, tissue architecture, cellular
density, composition of different cell types, and the presence of particularly sensitive
vascular components.

In general,

smaller tissue samples will be more uniform in

geometry and exhibit less thermal heterogeneity during freezing. Tissues with a more

10
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homogeneous cell type typically permit easier optimization of the cooling conditions
essential to preservation of the viability of the primary cell type.

Preservation of living cells for years can be achieved by storage at temperatures
of the order of -150PC to -200°C.

At such low temperatures, molecular motion is

inhibited so that all physiological and biochemical processes are essentially arrested.
Low-temperature

preservation

generally

involves

tissue freezing.

Biological

consequences of freezing primarily arise from three factors: the inhibitory effects of low
temperatures on chemical and physical processes; the physical effects of ice present in
the biological system; and the physicochemical effects o f rising solute concentrations as
the volume o f liquid water decreases during crystallization (Karow, 1981).

Freezing involves the crystallization of liquid water, and an aqueous solution will
have an equilibrium freezing point below which ice can be sustained in the solution /ice
system. Obviously, it is necessary for solutions to be below their freezing point for ice
formation to occur. When ice forms in a cryopreservation system, there w ill be a point
where solid and liquid coexist as crystals and free solution, and the solutes that were
contained in the liquid medium w ill be excluded from the ice crystal lattice and contained
within the residual liquid phase (the unfrozen fraction). The volume of this liquid is
significantly reduced when compared to the unfrozen volume and the effective solute
concentraion it contains is considerably increased.

11
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A consequence of this increased solute is that the freezing point of the residual
solution is lowered, and w ill continue to be lowered, as cooling continues and even more
water makes the transition to the solid phase. These events will impose a hyperosmotic
stress on any biological material entrapped in the ice. The residual liquid volume will
continue to reduce in size as cooling proceeds and an ice /solution system will exist until
the eutectic temperature is reached, at which point the dissolved solutes w ill crystallize
from solution forming an amorphous glass.

The formation of extracellular ice will impose stress on suspended cells and
tissues, particularly as they will be entrapped in the channels between growing ice
crystals. Ice will also have a potentially disruptive mechanical effect when it occurs in
extracellular situations, between cells of a tissue or organ.

The potential exists for

damage to the cells themselves, the interconnections with neighboring cells and to other
extracellular structures (Grout, 1991). Following ice formation, cells will be exposed
to a range of effects that result from the increasing hypertonicity of the residual
solutions. The volume and surface area of the cell membrane will be reduced due to
exosmosis and an increase in the concentration of cytoplasmic solutes will affect the
cytoplasmic organelles.

Intracellular ice formation is lethal and can be viewed as a failure of the
cryopreservation protocol. The avoidance of intracellular freezing by slow cooling does
not by itself guaranted survival. To minimize the effects of freezing damage, tissues are
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equilibrated with cryoprotectants prior to freezing. Permeating cryoprotectants such as
Me SO and glycerol are effective in minimizing damage to slowly frozen biological
2

systems. They allow water flux, out of cells during the freezing process and back into
them during the thawing phase, such that intracellular ice crystal formation is restricted
and reduces the effective ion /solute concentrations that can occur as a result of freezedehydration. This action can be seen from a study of NaCl/glycerol mixtures in which
a slowly-frozen 0.154 M NaCl solution is concentrated by a factor of approximately 15
by -10°C, but the addition of glycerol at a 1:1 ratio (by weight) reduces the NaCl
concentration to a factor of approximately 9, and a 9:1 addition reduces the salt
concentration even further to a factor of only approximately 3.5 at the same temperature
(-10°C) (Farrant, 1966). At slow-cooling rates, and assuming that the cryoprotectant is
equilibrated across the limiting membranes of the cells, this colligative action also
reduces the amount of cell shrinkage that will occur at any given temperature following
extracellular freezing, thus reducing the mechanical injuries (Ashwood-Smith, 1987).
The increase in viscosity of cryoprotectant solutions as the temperature is reduced may
also affect the rate at which water permeates out of the cell, which has implications for
the rate of cooling required to achieve the necessary water reduction in the cells / tissues
for successful cryopreservation. Slower rates of water permeation, i.e., longer cooling
times, are required as solution viscosity increases (Armitage, 1987).

Although many

cryoprotectants have been described, most freezing protocols use either Me SO or
2

glycerol in concentrations ranging from 0.5 to 3 molar.
cryoprotectants either at 4°C or room temperature.

Most researchers add the

The length of time required for
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osmotic equilibration at 4°C is substantially longer than at 37°C, and it has been
suggested that this may result in less stress to the cell and higher viability (Bank and
Brockbank, 1987). However, these agents are considered to be toxic and consideration
must be given to changes in their concentrations during the freezing process.

Nonpermeating

cryoprotectants

such

as

polyethyleneglycol

and

polyvinylpyrrolidone are large macromolecules. Their mode of action may be, in part,
colligative as they will become increasingly more concentrated in residual solutions as
freezing progresses, and have an effect on freezing point depression and the reduction
of ion concentrations (Conor and Ashwood-Smith, 1973). These cryoprotectants also
form supersaturated solutions of very high viscosity as the residual solution volume
decreases, for they do not crystallize readily from aqueous solutions. In this condition,
they absorb a certain amount of water, which is rendered effectively unfreezable
beneficially influencing ice formation in the system.

The cooling rate during cryopreservation should allow sufficient time for cell
shrinkage and water passage to the extracellular compartment. In general, a cooling rate
between 1°C and 5°C per minute is adequate for cryopreservation of allograft heart valve.
Storage of cryopreserved tissue should be a sufficiently low temperature so that gradual
growth of ice crystals over time is prevented. This temperature should be below the
glass transition point of the medium in which it is frozen in order to prevent chemical
reaction. The glass transition temperature of pure water is -139°C and freezing media
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are commonly in the range of -120PC. A convenient storage system is liquid nitrogen
at -196°C or the vapor phase of a liquid nitrogen (-150°C to -190°C).

Rewarming is

important, and a warming rate greater than 100°C per minute is usually required. Fast
warming is desirable and has been recommended with heart valves.

This rate is

generally achieved by immersion of the frozen tissue in a 42°C water bath directly from
the liquid nitrogen. The tissues are then cleansed of the cryoprotectant by a multistage
stepwise washing process, which prevents tissue damage in the normothermic state and
reduce the osmotic stress (May and Baust, 1988; Bank and Brockbank, 1987).

The advantage of cryopreservation is that truly long-term preservation, ranging
from months to years can be obtained, while the disadantage is in the lack of a complete
understanding of the mechanism of cryobiology, so that cryopreservation procedures may
produce significant damage as a result of ice formation during the freezing process. To
date, it has been virtually impossible to freeze a solid organ without having viability
markedly reduced following thawing.

Concerning

a second problem with allograft heart valves, valvular

imcompetence, there are two causes.

One cause is technical and which is surgical

procedure-dependent. The second cause is the single most important determinant of
long-term valve performance - primary tissue failure (Matsuki et al., 1988). Beach
commented that the key determinants of the long-term durability of allograft valves are
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technical excellence during surgery and the method chosen for graft preparation (Beach
et al., 1984).

Assuming that technical problems can be overcome, the remaining problem is the
avoidance of primary tissue failure.

Factors influencing allograft survival include the

conditions of procurement, the interval between donor death and graft dissection and
condition of storage, and methods of sterilization (Penta et al., 1984).

A ll of these

factors affect cellular viability (McGiffin et al., 1988).

Many authors have suggested that allograft heart valves containing viable cells
result in improved long-term performance compared to non-viable grafts and prostheses.
It has been shown that fibroblasts within aortic valves are actively engaged in both
collagen synthesis and degradation (Gross et al., 1974; Van der Kamp et al., 1979) and
it is thought that these cells are responsible for maintenance of the collagen matrix within
cardiac valves (Barnes et al., 1970; Gonzalez-Lavin et al., 1972). Failure of xenograft
(xenograft is defined as that organ grafts are exchanged between individuals of different
species.) tissues, caused by disintegration of the valve cusps, appears to be at least partly
related to the fact that there are no viable fibroblasts remaining within these valves
(Carpentier et al., 1974). Jeong has demonstrated better function and less calcification
in viable allograft valves (Jeong et al., 1976).

Accumulating clinical evidence suggests

that "vital" allografts result in better long-term performance compared to "non-vital"
grafts and prostheses (Murray, 1956; Barratt-Boyes, 1964; Angell et al., 1973; Barratt-
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Boyes et al., 1977; O ’Brien et al., 1989; Ross, 1987). A recently reported clinical series
of viable allograft aortic valves is much more optimistic. In this series, 92% (± 2 ) of
patients undergoing aortic valve replacement with a viable allograft were free from all
valve-related complications at 10 years after surgery, compared to 73% (+ 4 ) of patients
receiving a nonviable valve (O’Brien et al., 1989). In addition, long-term follow-up of
transplanted vital valve tissue revealed that fibroblasts of donor origin can persist more
than 9 years post-transplantation (O’Brien et al., 1989).

The persistence of viable endothelial cells may also be important in the function
and durability of transplanted heart valves.

Endothelial cells regulate transvalvular

equilibrium and physiological and metabolic functions in intact systems (Yankah et al.,
1985; Yankah et al., 1988).

The absence of endothelium may lead to insufficient

fibroblast nutrition, the formation of thrombi and calcification since thrombosis and
vascular tone are dependent upon the presence of an intact endothelial lining (Bank et al.,
1988) and endothelial cells may also play a role in nutrition of fibroblasts. Endothelial
cells are, however, a very delicate population of cells. One study of fresh human valve
cusps revealed that 88% possessed a well-defined endothelium (Innes et al., 1969)
whereas valves obtained within 24 hours post mortem did not (Van der Kamp et al.,
1981).

Evidence that endothelial cells survive with current processing and

cryopreservation techniques is, at best, poor and indeed the significance of intact
endothelial cells has yet to be demonstrated. Endothelial cells have been reported to
interact with immunocompetent cells, and this potential interaction with an intact
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endothelium could facilitate a rejection reponse (Brockbank and Bank, 1987).
Immunological rejection is particularly likely, since endothelial cells are known to
express histocompatibility antigens as part of their cell membrane (Moraes and Stastney,
1977). The presence of antibodies reacting against the surface antigens of the endothelial
cells of the allografts clearly demonstrate that the cells are immunogenic (Yankah et al.,
1987). Therefore, endothelial cell preservation may be a double-edged sword (Bank et
al., 1988). Further research is needed to evaluate the advantage or disadvantage of the
presence of endothelial cells in transplantated allograft valves.

Although the clinical evidence presented above suggests that cellular viability
(especially that of the fibroblasts) may be an important factor in valve durability, to date
there have been few published studies quantifying the percentage of viable cells
remaining in allograft valves (Van der Kamp et al., 1981; Al-Janabi et al., 1987). This
evidence is particularly true in the case of the fibroblasts and the role of these cells in
the maintenance of a valve ’s structural integrity via the production of the collagen
elastin/proteoglycan matrix is poorly understood (Van der Kamp et al., 1981; O’Brien,
1986; Khanna et al., 1981; Henney et al., 1982). It is generally agreed that properly
cryopreserved allograft valves may be vastly superior to any other prosthetic or
bioprosthetic device (McGregor et al., 1976). The primary question then is what is the
best way to properly cryopreserve an allograft valve?

There has been no detailed

published studies on cryopreserved heart valves currently used for transplantation.
Clearly, documentation is crucial in order to develop and refine methodologies to provide
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optimal valves for transplantation. Quantitative measurements can be used to determine
the effects of variables in processing for cryopreservation, such as prolonged warm
ischemic time, cold ischemic time, components of antibiotic treatment, treatment with
cryoprotective agents, and methods of storage of allograft valves. An evaluation of tissue
viability is crucial to the determination of the success of cryopreservation.

Techniques previously used to assess cellular viability include histology (Armiger
et al., 1983), tissue culture (McGregor et al., 1976), and autoradiography (Khan and
Gonzalez-Lavin, 1976). Histologic evaluation is inadequate since one cannot differentiate
live cells from dead cells. Tissue culture is an imprecise and difficult technique. It is
difficult to obtain quantitative data and does not indicate the distribution of the live cells
in relation to the tissue architecture, information which can be of significance in assessing
detrimental effects of pre-treatments as well as post-implantation changes on the valve.
Metabolic function assessed by the uptake of radioactively-labelled tracers is more
reliable. The uptake of tritiated thymidine into the DNA of dividing cells was used in
early studies (Gonzalez-Lavin & O’Connel, 1973), but is no longer considered
appropriate owing to the slow replication rates of fibroblasts.

The determination of

glucose utilization by the cells (McGiffin et al, 1988), the incorporation of tritiated
proline into collagen (Brockbank & Bank, 1987), and proline accumulation (Hu et al.,
1990) are more accurate indicators of metabolic function of a viable cell population.
Proline accumulation or incorporation by

viable cell population is quantifiable and

measures the accumulation rates of radiolabeled amino acids into metabolically viable
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cells and incorporation into proteins being synthesized by the viable cells. Since cells
must continually synthesize proteins de novo in order to remain viable, the test should
represent a reliable predictor of cell viability.

A heart is a hollow muscular pump located in the mediastinum, the space in the
thoracic cavity between the two pleural sacs. The heart lies between the lungs, behind
the sternum and costal cartilages, and in front of the thoracic diaphragm. The heart
consists of four chambers: the right and left atria and right and left ventricles. The right
atrium receives deoxygenated blood from the systemic (body) veins and passes it to the
right ventricle, which pumps it into the pulmonary (lung) arteries.

The pulmonary

arteries carry deoxygenated blood to the lungs for oxygenation. The left atrium receives
oxygenated blood from the pulmonary veins and passes it to the left ventricles, which
pumps it into the systemic arteries. The systemic arteries carry oxygenated blood to the
tissues of the body, where it gives up oxygen and picks up carbon dioxide (Fig. 1). The
disertional flow of blood is mediated by valves positioned between the various chambers
of the heart.

Cardiac valves are composed of dense connective tissue. The valve between the
right atrium and the right ventricle is the tricuspid valve, and the valve between the left
atrium and left ventricle is the mitral valve. The outflow valve of the right ventricle is
the pulmonary semilunar valve and that of the left ventricle is the aortic semilunar valve.
The valves of the heart have a similar histological structure in being covered on both
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Fig. 1: Anatomy of the human heart and accessory great vessels. Arrows indicate
of blood flow through chambers and great vessels of adult heart.
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sides with endothelium and having a middle supporting layer of dense connective tissue
containing numerous elastic fibers. The major cells in the matrix are fibroblast cells
which are responsible for synthesis of three major components: collagen, elastin and
proteoglycan.

Collagen molecules are relatively long (about 280nm) and narrow (about 1.5nm)
consisting of three polypeptide chains wound together in the form o f a triple helix. The
chains are termed alpha chains and each chain consists of sequences of essentially three
amino acids repeated along its course. The first amino acid in a collagen protein of each
sequence may be any of a variety of amino acids, however, the second amino acid is
usually either proline or lysine, and the third residue is always glycine.

Seven types of collagen are recognized, each differing in the amino acid
composition of the alpha chains. These variations provide the differences in physical
properties that are required by different tissues. Type I collagen, which is characterized
by low carbohydrate content and contains less than 10 hydroxylysines per chain, is found
in heart valves, bone, skin, tendons and intestinal and uterine wall tissue. There are more
than 20 hydroxylysines per chain in Type II collagen which is present primarily in
cartilage. The hydroxyproline and glycine contents are very high in Type II I collagen
which is mainly found in blood vessels, newborn skin, and scar tissue. In basement
membrane collagen (Type IV ), the hydroxyproline content is more than 40 residues per
chain and it has a much highter content of carbohydrate than Type I, II, or III. Type V
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collagen also has a higher content of carbohydrate, as well as a relatively high content
of glycine and hydroxyproline. It is found on cell surfaces and exocytoskeletons. Type
V I collagen contains a high concentration of cysteine and tyrosine and it has relatively
large globular domains in the

telopeptide region and equimolar amounts of

hydroxylysine and hydroxyproline. Type V I collagen is present in low amounts in aortic
intima, placenta, kidney, and skin (Halkerston, 1988).

Proteoglycans are another class of macromolecules present in connective tissues
(Hendley et al., 1978) which are also found in the matrices of calcifying and
noncalcifying tissues (Campo and Tourtelotte, 1967). They consist of a protein core to
which glycosaminoglycan (GAG) chains, consisting of repeating disaccharide units, are
covalently attached (Hardinghametal., 1976). The repeating disaccharide units are, for
the most part, the

hexuronic acids, D-glucuronate or L-iduronate, linked to an N-

acetylhexosamine. The amino groups of the basic sugars are N-acetylated or N-sulfated,
the latter marking the glycosaminoglycans as being acidic in nature. The presence of
these "acidic" macromolecules affects the properties of the tissue in which they are
found, enabling the tissue to retain water and giving it permselective and viscoelastic
properties.

With respect to calcification of the allograft heart valve, researchers are left with
a situation similar to that with respect to cellular viability.

Minimal information is

available regarding the effects of cryopreservation on the tendency of the valve to calcify
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following transplantation. It is a well accepted axiom that transplanted allograft heart
valves w ill calcify with time and that this calcification will occur most commonly in root
and conduit tissues rather than cuspal tissues.

It has been suggested that the

chemical/biochemical nature of the implanted tissues, at the time of implantation, most
likely determines the rate and extent of calcification (Wolfinbarger and Hopkins, 1989).

Valve calcification is generally considered as the most important single cause of
valve dysfunction (Gallucci et al., 1986; Milano et al., 1984) and has been studied
primarily in tissues implanted for months and/or years.

This process, noted in all

patients, is particularly pronounced in younger recipients. Calcium deposition may lead
to valve stenosis and mechanical fragility (Gozalez-Lavin, 1988b) and results in
degeneration and dysfunction.

Calcification has been suggested to be initiated in

organelles (e.g. mitochondria and nuclei) of devitalized connective tissue cells (Valente
et al., 1984) and a variety of methods have been examined for the prevention of
calcification (Hilbert et al., 1989).

Mineralization in living organisms is defined as the deposition of inorganic
chemical compounds under normal or pathologic conditions. In mammals, mineralization
is synonymous with calcification, in as much as the major inorganic minerals deposited
are calcium compounds. Mineralization processes in the body are controlled by
physicochemical and cellular regulation of hydroxyapatite (HA) nucleators and inhibitors.
The process of biologic calcification in which hydroxyapatite, or some other Ca-
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containing mineral is deposited within an organic matrix has been extensively reviewed
(Alcock, 1972; Anderson, 1984; Anderson et al., 1970). In brief, for any insoluble or
sparingly soluble crystalline material to form, ions or groups of ions (mainly calcium and
phosphate) must come together with the structure of the crystalline material that can
persist in solution. Nucleation sites are required for mineral deposition because the
calcium phosphate molecule itself is too small for aggregation.

Zimmermann et al.

(1991) summarized that these nucleation sites can be osteoid, phospholipids, necrotic
cells, and cell remnants, in addition to the "holes" in the collagen fibers, which for a
long time were considered the only nucleation sites (Vaughan, 1981). The nature of the
mineral is a poorly crystalline, carbonate-containing analog of hydroxyapatite
(Ca10(PO4)6(OH)2) (Doi et al, 1979).

Biological calcification depends on the interaction of cells, extracellular
macromolecules and other matrix components.

The extracellular macromolecules

regulate the manner in which hydroxyapatite mineral is deposited. Smaller molecules
and ions, such as pyrophosphate (Alcock, 1972), carbonate, magnesium (Blumenthal et
al., 1977) and nucleoside triphosphates (Blumenthal, 1977) as well as certain hormones
(Peck and Klahr, 1979), and nonmatrix proteins (Hendley et al, 1978) are involved.
Certain enzymes (e.g. alkaline phosphatase) (Salomon, 1974) are very closely associated
with the initial calcification of epiphyseal cartilage (Anderson, 1969).
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Synthesis and secretion of the components of the extracellular matrix is a primary
function of specific cells within the calcifying tissue. These cells are also believed to
provide storage sites for calcium and phosphate ((Mattews, 1971), thus creating the
microenvironments in which mineralization occurs. The mitochondria are the principle
cellular organelle concerned with the control of cellular, and possible extracellular,
calcium and phosphate concentrations.

In many calcifying tissues, phosphatase-rich

membrane-bound bodies of cellular origin, localized in the extracellular matrix (matrix
vesicles), appear also to be the initial site for mineral deposition (Anderson, 1980). In
the epiphyseal growth plate, for example, matrix vesicles progress from a mineral-free
state, gradually loading their membranes with calcium and then calcium and phosphate,
until both the vesicle and its outer surface are inundated with mineral. This mineral then
spreads through the matrix. (A li et al., 1971).

In the collagenous tissues the c-axis of the hydroxyapatite mineral is usually
aligned parallel to the collagen fibers, and the mineral crystals are deposited in a manner
related to the periodicity of the collagen fibrils (Heeley and Irving. 1973).

The

molecular repeat in collagen might provide a suitable lattice to serve as a template for
the formation of the first crystalline mineral.

The initial mineral deposits generally

appear at discrete sites, embedded within, or upon, the collagen fibrils. The ability of
collagen to promote mineralization appears to depend on the structural arrangement of
the collagen fibrils (White, 1977). Modification of the collagen structure, by blocking
of the carboxylic acid groups of aspartate and glutamate, can completely prevent in vitro
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apatite deposition (Davis and Walker, 1972). Collagen, in conjunction with the cells and
other macromolecules, may also regulate mineral size.

Evidence for the role of proteoglycans in calcification initially came from
histochemical and autoradiographic studies and later from biochemical investigations in
which the proteoglycan content was estimated based on the uronic acid and / or
hexosamine content o f the tissue. A ll studies were consistent in demonstrating that there
was significantly less glycosaminoglycan in calcified than in noncalcified tissues
(Silbermann and Frommer,

1974).

A decrease in glycosaminoglycan at the

mineralization front has also been reported in dentin (Engfeldt and Hjerpe, 1972),
articular cartilage, and bone osteoid. There is evidence that the aggregate population of
proteoglycan seems to decrease in size as mineralization proceeds. Blumenthal has also
shown that the most likely primary mechanism of action of proteoglycans in inhibiting
hydroxyapatite (HA) formation is due to the extended spatial conformation of these
enormous macromolecules that sweep out large domains in solution as they tumble about,
creating regions of "excluded volumes" where formation and growth of HA crystals are
physically interfered with (Blumenthal,

1989).

Conformational modifications,

disaggregation or other structural alteration of the proteoglycans may be caused by
certain enzymes (Guenther et al., 1974). The lysozyme, which digests proteoglycans,
is localized extracellularly in cartilage (Granda and Posner, 1971; 1971; Kuettner etal.,
1975). It has been implicated in the calcification process in that it is found in increased
relative concentration in areas where calcification is occurring.

In 1959 Engfeldt
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(Engfeldt et al., 1959) reported that injection of papain (an enzyme that digests the
protein core of the proteoglycan subunits) into the growth cartilage of young dogs leads
to a narrowing of their growth plates, with an extended area of calcification, suggesting
that disruption of proteoglycans accelerates the process of calcification.

Blumenthal

(1989) has demonstrated that if the protein core is distrupted, the proteoglycans can no
longer exert their in vitro effect. Howell and Pita (1976) also demonstrated that treating
aspirates of rat hypertrophic cartilage with hyaluronidase leads to a deposition of mineral,
again emphasizing that proteoglycan modification facilitates mineralization.

Membrane lipids, especially the acid phospholipids, have been shown to be
involved in the initiation of mineralization. These lipids are present in the membranes
of extracellular matrix vesicles, plasma membranes, and membranes of cellular organelles
such as mitochondria. They induce in vitro hydroxyapatite proliferation from metastable
calcium-acidic phospholipid-phosphate complexes which are believed to have structural
features that promote hydroxyapatite nucleation and growth (Boskey and Posner, 1976).
Irving demonstrated that lipids were present in growth plate cartilage matrix at the
calcification front (Irving, 1963).

Acidic phospholipids, particularly phosphatidyl serine

and phosphatidyl inositol were shown to have a strong affinity for ionic calcium with
increased Ca2+ affinity in the presence of P043' (Cotmore et al., 1971).
suggested that

Boskey

enzymes, such as the phospholipases, which alter the structure and

properties of the phospholipids, can prevent or retard the formation of calcium
phosphate-acidic phospholipids complexes (1981).
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It has been reported that alkaline phophatase is a major enzymatic activity in
extracellular matrix vesicles (Anderson, 1969). In skeletal and dental tissues, normal
(i.e., physiological) mineralization largely occurs initially on extracellular membrous
particles derived from cellular remnants (i.e., matrix vesicles) (Anderson, 1984). There
is substantial evidence that the enzyme alkaline phosphatase is important in the
pathogenesis of physiological mineralization and inhibition of alkaline phosphatase
activity appears to reduce mineralization (Anderson, 1980). Robison, in 1923, suggested
that the enzyme alkaline phosphatase, which he found in excess in areas of calcification,
hydrolyzed phosphate esters and produced an excess of free inorganic phosphate ions,
thus elevating the (Ca++) X (PO-) ion product at specific calcification centers to a degree
necessary to produce precipitations of apatite. The elevation of this enzyme in bone is
still regarded as an indication of active bone metabolism and it is now known to play a
vital part in the metabolism of matrix vesicles as one of the factors raising the (Ca++)
X (PO-) product (Robison, 1923).

The idea of a study associated with the tendency of heart valves to calcify
following implantation derived primarily from the studies of cartilage mineralization and
demineralized bone implantation. It has been suggested that osteoinduction is responsible
for the process of bone regeneration after the implantation of demineralized bone grafts.
Osteoinduction is defined as the process of differentiation of fibroblast-like migratory
mesenchymal cells into osteoprogenitor cells in response to calcified tissue matrices that
are predemineralized in vitro or in the course of resorption (Urist, 1976a; Covey and
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Albright, 1989). The osteoinductive sequence of events include conversion of connective
tissue into cartilage, ingrowth of host blood vessels, ossification and subsequent
calcification. Physiological osteoinduction occurs in response to the native structure of
extracellular substances of calcifiable calcified-tissues such as epiphyseal cartilage or
bone matrix.

In other conditions, osteoinduction may occur when migratory

mesenchymal cells are in contact with dentin, gall bladder epithelium, calcified
connective tissue, etc. ( Huggins and Urist, 1970; Ohgushi et al., 1988). Urist (1965)
successfully demonstrated induced ectopic new bone formation in experimental animals.
In that study acid-demineralized bone segments were implanted subcutanously.

The

implants were first observed to be infiltrated with circulating macrophages, fibroblasts
and other connective tissue cells. In later stages, after partial resorption of matrix and
vascularization of the area, chondroblasts were observed, and they gradually
demonstrated osteoblast-like characteristics. These phenotypic changes were consistent
with the hypothesis that fully differentiated fibroblast cells retain the transformability that
can be elicited by inducers. Fibroblast cultures from bone marrow, for instance, can
form bone in diffusion chambers whereas cultures of fibroblasts from other connective
tissue will only form bone in the presence of an inducer (Urist, 1977).

In normal

physiological conditions there is very high alkaline phosphatase activity in osteogenic
cells but very low activity in fibroblast cells. Alkaline phosphatase activity is therefore
a major quantitative reference in the phenotypic transformation of fibroblast cells toward
osteogenic cells.

It is suggested that a similar process may occur following the

transplantation of heart valve leaflet tissue since both bone and heart valve tissues are
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connective tissues and show similar histological structures and biological composition.
Wheatley and McGregor (1977) found that cells cultured from known viable allograft
valves explanted at 1,4, and 8 weeks in an experimental dog model have either host or
donor chromosomes. These results suggested that the implanted allograft valves were
infiltrated with fibroblasts or other connective tissue cells.

Gonzalez-Lavin and his

colleagues recently also reported, using cytogenetic analysis, that host fibroblast cells
repopulated the inner one third of the implanted donor valve leaflets (Gonzalez-Lavin et
al., 1990).

The research described here was designed to answer some of these questions.
What changes occur to the cellular viability and calcification potential of variously
processed heart valves and whether the processing and / or cryopreservation protocols
may be modified to reduce or eliminate these changes. The aims and objectives of this
project are conveniently divided into the following sections:

I. Evaluation of the morphology of normal heart valves. II. Development of a
quantitative bioassay to measure the metabolic viability of the cells in heart valve tissue.
III. Evaluation of cellular metabolic viability in heart valve tissue with prolonged warm
and cold ischemic time. IV . A study of antibiotic disinfection: including the effectiveness
of antibiotic disinfection and effects of antibiotics on cellular metabolic viability in heart
valve tissue.

V . Assessment of toxicity of cryoprotectants on heart valve tissue:

including the measurement of the penetration rates of glycerol and MezSO into aortic
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conduit tissue and cellular metabolic viability of heart valve tissue treated with glycerol
and MezSO. V I. Optimization of storage methods: in vapor phase or liquid nitrogen.
V II. Determination of optimal perfect thawing rates for cultured porcine heart valve
fibroblasts and measurement of concentrations of cryoprotectants in the tissue post step
wise dilution process. V m . Assessment of the tendency of heart valves to calcify by
determining the inducibility of alkaline phosphatase activity by variously processed heart
valve tissues.
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MATERIALS AND METHODS

I . DISSECTIO N AND PROCUREMENT O F H EAR T V A LV E TISSUE

Procurement and Dissection of Human Heart Valves:

Following sterile cardiodiectomy (Cardiodiectomy is defined as the removal of the
heart from the donor), donor human hearts were rinsed in cold sterile Ringer’s lactate
to remove as much residual blood as possible.

The heart was then packed in

approximately 300 ml of cold Ringer’s lactate solution by using double sterile bags.
After packaging, the donor hearts were shipped at 4°C on wet ice, with a copy of
pertinent donor information and a blood sample for serology testing. A ll hearts must be
received by LifeNet-Virginia Tissue Bank within 24 hours of removal. The hearts were
kept at 4°C and dissected using a specially designed cooling apparatus. The pericardium
and connective tissues were removed from the heart, isolating the aorta and pulmonary
arteries. The right and left coronary artery origins were located and ligated with 3-0
silk. Approximately 5 mm from the ligature,

the aorta was further dissected to the

myocardial junction. The aorta and pulmonary artery were then separated. Beginning
at the right ventricle, the entire pulmonary outflow tract was removed from the heart.
The left ventricle was opened, the cordae tendenae of the anterior mitral leaflet were
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divided, and the aorta, aortic valve and anterior mitral leaflet were removed from the
heart as a single graft. Excess myocardium, fat, and connective tissues were dissected
from the aortic and pulmonary specimens. The grafts were sized, determining internal
valve root diameters and all conduit lengths.

The specimens were then placed in a tissue culture medium (RPM I 1640 medium)
amended with cefoxitin, lincomycin, polymyxin B, and vancomycin (Lange and Hopkin,
1989). The allografts were maintained at 4°C for 48 hours with cultures being taken at
24 hours intervals for microbiological analysis. I f the valves were to be cryopreserved,
they were packaged in a solution of tissue culture medium (RPM I 1640 medium)
amended with 10% fetal calf serum (FCS) and 10% dimethyl sulfoxide (Me^SO) and
computer control-rate frozen with liquid nitrogen at -1°C per minute. The allografts were
then placed in liquid nitrogen vapor phase storage (-130°C to -190°C) and released when
all cultures and serology studies had been completed.

The frozen specimens were

shipped to the laboratory at Old Dominion University in specially designed cryogenic
containers. These containers were precooled to -190°C with liquid nitrogen and are
guaranteed to maintain temperatures below -150°C for up to fourteen days. This shipping
system prevents potential damage due to thermal fluctuations during shipment. The
allografts were immediately placed into the ultralow freezer or a liquid nitrogen storage
device where they were held at temperatures below -150°C until used.
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Procurement and Dissection of Porcine Heart Valves:

Tissues utilized in research included both porcine and human heart valve tissues.
The human tissue was procured by staff of LifeNet Transplant Services (LifeNet) using
procedures approved by the American Association of Tissue Banks and as modified as
this study proceeded. The porcine tissue was procured with the assistance of Gwaltney’s
staff, Gwaltney meat-packing company, Smithfield, VA. The general age, and weight
of the pigs were nearly equivalent and the hearts were removed within 20 minutes of
death. The porcine hearts were subsequently processed in a manner similar to that used
by LifeNet in the processing of human heart valves as described above. Each porcine
heart was washed with 200 ml of cold Ringer’s lactate solution to remove as much blood
as possible and intact hearts were transported to the laboratory in tissue culture medium
(RPMI 1640 Medium) on ice.

The transport time was approximately forty-five

minutes.

Valve leaflets (aortic and pulmonic) were quickly dissected from the hearts in a
manner analogous to that used in dissection of human tissues and cuspal tissues were held
in Eagle’s Minimum Essential Medium (Eagle’s M EM , Media-Tech, Herdon, VA) on
ice, until used in an assay. For the purposes of this study, "fresh" valves are defined as
fresly procured tissues which have been transported on ice to the laboratory, dissected
out of the heart, washed and held on ice in Eagle’s M EM . "Antibiotic sterilized" valves
are defined as fresh valve tissue which has subsequently been incubated in the different
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antibiotic solutions. Cryopreserved heart valves represent those valves which have been
"sterilized" for 24 hours in antibiotics, cryoprotectant added and the valves frozen at -1°C
/ minute, stored at -150(C , thawed, cryoprotectant removed by dilution, and the tissue
then treated in a manner similar to fresh tissues.

I I . RADIOLABELED PRO LINE AND IN U L IN TRANSPORT ASSAYS FOR C ELL
V IA B IL IT Y

Heart valve leaflet tissue sections, in 2.25 ml Eagle’s M EM , used for assessment of
cellular metabolic viability were transfered to 37°C and after 10 minute equilibration
periods, radiolabeled proline (0.25 ml) or inulin (0.25ml) were added to final
concentrations of 1 uci/O.lumole/ml. After incubation for specific periods of time at
37°C, the valve tissue sections were washed 3 times for 2 minutes each with cold
Dulbecco’s phosphate buffered saline (D ’PBS) supplemented with 1 mM nonradiolabeled
proline or inulin and then placed in 0.8 ml of IN NaOH. The tubes containing the tissue
sections were tightly covered with Parafilm and placed in a 60°C heating block for 2 to
3 hrs. When tissue solubilization was completed, aliquots of the solution were taken for
use in a Lowry protein assay (Lowry et al., 1953). Bovine serum albumin was used as
a standard for the protein assays. Identical aliquots were taken and added to 7 ml of
scintillation fluid (Scinti Verse Bio-HP, from Fisher Scientific Company) and counted in
a liquid scintillation counter (Beckman LS 170, Liquid Scintillation System). The raw
data were converted to nanomoles proline (inulin) accumulated / mg tissue protein using
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an "in-house" data calculation program which included values for counting efficiency,
protein concentration, and specific activity of radiolabeled substrate.

m . EFFECTIVENESS OF A N TIB IO TIC D ISIN FEC TIO N

Filtration techniques were used to assess the effectiveness of antibiotic disinfection
of cardiovascular tissues. Cultures of appropriate bacterial strains (E. coli, S. aureus, S.

epidermidis, S.pneumoniae, C. petfringens, and S. faecalis) were grown overnight.
Tissue culture medium (RPMI 1640 medium) supplemented with antibiotics (amphotericin
B, polymyxin B, cefoxitin, vancomycin, and lincomycin) were prepared.

The

concentrations of the antibiotics are shown in Table 1. Overnight bacterial cultures of
bacteria (1 ml) were added to 9 ml of tissue culture medium supplemented with
antibiotics and 1 ml of this mixture was transfered to a second 9 ml of tissue culture
medium supplemented with antibiotics.

This step was repeated until the dilution

provided for a bacterial cell density of less than 1 colony forming unit (CFU) per ml of
medium. Each dilution set was filtered when the cultures of appropriate bacterial strains
had been incubated in the tissue culture medium supplemented with antibiotics for 0, 6,
12, 24, 48 hrs, the filter was washed with sterile water, and incubated at 37°C in the
appropriate medium for 24 and 48 hrs or until bacterial growth was observed, but no
longer than 48 hrs. Data were presented as " + " for positive bacterial growth from the
filter or

for negative bacterial growth from the filter. Bacterial densities ranging
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from greater than one million bacteria /ml to less than one bacterium /m l were tested in
the 1 to 10 dilutional series. Growth from any dilution was indicated as positive.

IV . Q U A N TITA TIO N O F Me.SO AND G LYCERO L IN PO RCINE A O RTIC
C O NDUIT TISSUE

Quantitation of Me^SO bv High-Performance Liquid Chromatography:

In order to assess the level of N^SO in the heart tissue, a high-performance
liquid chromatography (HPLC) method (Carter, 1991) was modified to analyze MejSO
in porcine aortic conduit tissue.

HPLC apparatus. The apparatus consisted of a ISCO Model 2350 pump coupled to an
ISCO FL-2 V4 variable wavelength detector. Data were analyzed with a plotting
integrator linked to a Multisync personal computer using ISCO’s analytical
ChemResearch software (IB M ). The column used was an ISCO LC Spherisorb ™ C18
(3um) reverse phase matrix. An ISCO LC Spherisorb Q g (3um) guard Cartridge was
placed between the injector and the column.

HPLC assay method. The mobile phase contained 10% methanol (vol/vol) in high purity
deionized water. The flow rate was 1.0 ml/min and the detector was set at 214 nm. All
samples were diluted as needed in 10% methanol and centrifuged for 5 minutes in a
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Brinkmann Eppendorf microfuge (Model 5412) and filtered through a 0.22 micron nylon
filter prior to injection. Each sample, consisting of a 10 ul aliquot of either a standard
Me SO solution or extracts of cardiovascular tissues was injected onto HPLC for
2

analysis.

Extraction o f M efiO from porcine aortic conduit tissue. Porcine aortic conduit tissue was
dissected from freshly procured hearts (approximately 5 grams in weight) and placed into
45 ml RPM I 1640 medium supplemented with 10% FCS and 10% (1.4M ) MejSO. After
specific time intervals, tissue samples were removed and blotted dry on a Kimwipe,
placed in a glass bottle containing 10 ml of 10% methanol per gram of tissue wet weight.
The bottle was tightly capped. The tissue was extracted for at least 24 hrs at room
temperature. For tissue samples of less than 5 grams, this time was sufficient interval
to allow equilibration of MejSO with the tissue and surrounding methanol solution (data
not shown). An aliquot of the extract was removed, diluted 1/200 with 10% methanol
and assayed for MejSO.

Known concentrations of M e^O , prepared in RPMI 1640

medium supplemented with 10% FCS (ranging from 1.1 mg / ml to 11 mg/ ml) were used
to generate a standard curve. The samples were centrifuged and filtered as described
above.

Determination o f tissue dry weight. The 10% methanol was removed from the bottle and
replaced with 100% methanol (10ml per gram of tissue wet weight). After 24 hrs the
methanol was removed and replaced with absolute ethyl alcohol.

The tissue was
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incubated overnight and then the alcohol was aspirated from the bottle. The bottle
containing the tissue was placed in a venting fume hood to evaporate the residual alcohol.
The dried tissues were weighed to the nearest 0.1 mg.

Calculation o f MefiO concentration in tissue samples. To determine the concentration
of MeaSO in the aqueous compartment of a tissue sample, the water volume of the tissue
must be calculated. This value is the difference between the wet and dry weights, in
grams, multiplied by 1 ml/gram. Using the calculated water volume of conduit tissue,
the actual dilution of the tissue’s aqueous compartment during the extraction procedure
can be calculated. The following equations show how the concentrations of MeaSO in
the tissue samples were calculated.

Tissue Wet Weight - Tissue Dry Weight = Tissue Water Weight

[1]

Tissue Water Weight x lm l/g = Tissue Water Volume

[2]

Tissue Water Volume + (lOml/g x Tissue Wet Weight)
Tissue Water Volume
= Tissue dilution factor

[3]

= Tissue [MeaSO]

[4]

Peak area _ Y intercept b
extract
(from standard curve)
----------------------------------------------- x Tissue dilution factor
Slope M (from standard curve)
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The tissue wet and dry weights were determined as described above.

The

difference (Eq. 1) in these values is assumed to be representative of the weight of water
in the sample, which is converted to volume in Eq. [2] by dividing the water weight by
the density of water. The tissue dilution factor calculated in Eq. [3] is the actual dilution
of the tissue aqueous compartment that arises when 10 ml of 10% methanol was used to
extract each gram wet weight of tissue. The peak areas referred to in Eq. [4] were those
for MejSO peaks on the HPLC chromatograms from each tissue extraction. Slope M and
Y intercept b were generated from the standard curve. For example, a tissue sample
with a 1 gram wet weight may have a dry weight of 0.15 gram. Thus, the water content
of the tissue would be 0.85 gram or 0.85 ml. Since the 1 gram tissue sample would be
extracted with 10 ml of 10% methanol, the actual dilution of the aqueous compartment
of the tissue would be 0.85:10.85 (V:V) rather than 1:10 (V :V ).

Quantitation of Glycerol bv Refractometer:

The levels of glycerol in the tissue samples were determined using a ABBE-3L
Refractometer.

Porcine aortic conduit tissue was dissected from porcine hearts and

trimmed to approximately 5 grams wet weight. The tissue was placed into RPM I 1640
medium supplemented with 10% FCS and 15% glycerol (2 M ).

After specific time

intervals the tissue samples were removed and their wet weights determined. The tissue
samples were placed in glass bottles and 10 ml of RPMI 1640 medium containing 10%
FCS was added per gram of tissue wet weight for at least 24 hrs. The refractive index
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of each sample was measured using a ABBE-3L Refractometer. The aortic conduit
tissue was placed into 100% methanol (10 ml per gram tissue wet weight) for 24 hrs.
The tissue was then transfered to the same amount of absolute ethyl alcohol overnight.
The alcohol was aspirated from the bottle and the tissue allowed to dry. The dry weights
of the tissue were determined using a balance to the nearest 0.1 mg. Tissue dilution
factors were calculated by the method described above for MejSO.

Known

concentrations of glycerol in RPM I 1640 medium containing 10% FCS were used to
generate a standard curve of refractive index versus glycerol concentration.

V . M EASUREM ENT O F O SM O LA LITY

Approximately 5 grams of aortic conduit tissue was placed into 45 ml of RPMI
1640 medium supplemented with 10% FCS and either 10% MejSO or 15% glycerol at
both 4°C and 37°C such that the final total volume was 10 times that of the tissue
volume. At approximate time intervals, 250 ul aliquots of medium were removed and
diluted 1:5 with RPM I 1640 medium supplemented with 10% FCS. The osmolalities of
each aliquot were determined using an Advanced Wide-Range Osmometer (3W2) which
had been previously calibrated using known osmolality standards.
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VI. SCANNING ELECTRON MICROSCOPY

Tissue sections examined using the SEM were fixed by immersion in 2.5%
glutaraldehyde, 2% paraformaldehyde in a 0.1 M sodium cacodylate buffer with a pH
of 7.4 for 24 hours at 4°C.

The tissue sections were then rinsed in 0.1 M sodium

cacodylate buffer, three times for 10 minutes each rinse. Secondary fixation included
immersion in 2% osmium tetroxide in a 0.1 M sodium cacodylate buffer for 90 minutes.
The tissue sections were rinsed again in sodium cacodylate buffer, and dehydrated
through a series of 10 minute immersions in 30%, 50%, 70%, 95% and 100% ethanol
(two 10 minute immersions at room temperature in 100% ethanol solution) followed by
100% acetone for 10 minutes at room temperature. Samples were dried using a Denton
critical point dryer. Valve tissue sections were then carefully mounted on aluminum
stubs such that both the ventricular and aorta surfaces could be viewed. A gold/palladium
coating of 150 A was applied using a polaron SEM Autocoating unit E5200 and the
valves viewed using a Cambridge stereoscan 100 at accelerating voltage of 5 KV and
10KV.

Vn. CELL CULTURE

The heart valve leaflets dissected from freshly procured porcine hearts were rinsed
in phosphate buffered saline with penicillin (5001.U./m l) and streptomycin (500mcg /m l)
3 times for 5 minutes each rinse. The tissue was minced aseptically into small pieces.
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The tissue pieces were transfered to T-25 culture flasks containing 3 ml of Alpha
Minimum Essential Medium (GIBCO Company) supplemented with

10% fetal calf

serum and antibiotic mixture (20 units/ml of penicillin, 20 units/ml of streptomycin and
O.lmg/ml of lincomycin). The culture flasks were placed upside down in the incubator
until the tissue sections attached to the flask and fibroblasts were observed. The tissue
biopsies were removed and the culture medium (alpha Minimum Essential Medium) was
routinely changed twice a week. The cells were cultured at 37°C in a Queue humidified
C 0 2 incubator. Upon reaching visual confluence, the primary cultures were trypsinized
by pouring off the old medium and adding 3 ml of 0.05% trypsin+0.53mM EDTA
(GIBCO Company) for 4 minutes.

Once the cells were dislodged, 3 ml of alpha

Minimum Essential Medium supplemented with 10% FCS was added to the flask to stop
the trypsinization process.

The cell suspensions were collected and centrifuged in a

centrifuge at low speed for 5 minutes. The cell pellets were resuspended in alpha
Minimum Essential Medium

and subcultured.

The cells were maintained in alpha

Minimum Essential Medium supplemented with 10% fetal calf serum.

Vm. TH A W IN G

The porcine heart valve fibroblasts (passage 4 and 5) were cryopreserved. Briefly,
porcine fibroblasts were harvested by trypsinization as described above and centrifuged
at 3000 rpm for 4 minutes.

Cell pellets were then resuspended in cryopreservation

medium (10% fetal calf serum and 10% M e^O in RPMI 1640 medium) to a cell density
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of approximately 2 million cells per ml.

Cell suspensions were dispensed as 1 ml

aliquots into Cryogenic vials (Coming).

Vials were placed into styrofoam freezing

containers and stored at 4°C for 30 minutes. The containers were then placed at -20°C
for an additional 2 hrs, followed by placement in a freezer (-80°C) for an additional 24
hrs. Finally, the vials were transfered to and stored in a ultralow freezer (-150°C) until
used.

During the thawing procedures, 5 separate Cryogenic vials were thawed in water
baths at 4°C, 20°C, 37°C, 45°C, 75°C, respectively. Temperatures in each vial were not
allowed to rise above 5°C. Once the cells were thawed completely, they were stained
with trypan blue dye (0.4% trypan blue in Dulbecco’s Phosphate Buffer Saline), and
counted in a hemocytometer where cells staining blue were considered metabolically
"dead" and their number added to the number of "clear" cells (i.e. living cells), to
determine total cell number. The "dead" cell number were divided by the total cell
number to get the percentage of "dead" cells. Each assay was performed with triplicate
vials and in three separate experiments. The time required to thaw the cells in each vial
was recorded and used to calculate the thawing rate.

IX . A LK A LIN E PHOSPHATASE ANALYSIS

The alkaline phoshatase activities in porcine fibroblast cell cultures induced by
porcine heart valve tissue with different warm ischemic times (0, and 24 hours), cold
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ischemic times (0, 24, 48, and 72 hours), and post antibiotic treatment were assayed by
a modification of the procedure described by Maranto and Schoen (1989). T-75 tissue
culture flasks containing 30 ml of Alpha Minimum Essential Medium supplemented with
10% fetal calf serum and antibiotic mixture (concentration described above) were seeded
with 2 million porcine fibroblast cells.

Porcine heart valve leaflet tissue (0.2 gram,

minced fragments of approximately 0.3 x 0.3 cm) were added to each flask shortly after
cell addition. Alkaline phosphatase activities were typically measured on the day when
the cells reached visual confluence except where otherwise indicated.

Cells in T-75 tissue culture flasks were dislodged by mechanical scraping in the
presence of 1.5 ml/flask of hypotonic solution (deionized water). An additional 1.5 ml
of deionized water was added to rinse the flask and a total volume (3 ml) was collected
for each flask of cells harvested. The cells were sonicated with a Virsonic cell disrupter
(The Virtis Company, Model 16-850) for 20 seconds. The lipid components in this
suspension were extracted using an equivalent volume (3 ml) of n-butanol, by gently
shaking the mixture. After centrifugation at 2500 rpm using a Damon / IEC Division
centrifuge (IEC Model HN-S) for 10 minutes, the aqueous layers containing cell extracts
were collected for alkaline phophatase assays. An aliquot (0.8 ml) of 0.15 M 2-amino-2methyl-1-propanol (pH =10.4) buffer solution was added to each 1 ml of cell extract.
The well-mixed solution was then incubated at 37°C for 5 minutes to exhaust
endogeneous substrate. p-Nitrophenyl phosphate (PNPP) substrate (0.2 ml) was added
and the solution was incubated at 37°C for 30 minutes. The reaction was terminated by

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

adding 30 ul of IN NaOH, and the absorbance at 405 nm was measured using a Gilford
Stasar spectrophotometer. Authentic p-nitrophenol (PNP) was used to create a standard
curve and the absorbance values in the experimental solutions were converted to an
equivalent amount of PNP. An aliquot of each cell extract was used to determine the
protein concentration (Lowry protein assay as described above).

The data were

expressed as units of alkaline phosphatase activity per gram cell protein. One enzyme
unit was defined as the activity that would convert one umole of PNPP (i.e. yield 1
umole of PNP) per minute at 25°C. Authentic alkaline phosphatase (Sigma Chemical
Company) was utilized to validate the assay.

X . S TA TIS TIC A L EVA LU A TIO N O F DATA

Data from the transport assays were recorded as nanomoles amino acid per mg tissue
protein. Data from the alkaline phosphatase assays were expressed as units of alkaline
phosphatase activity per gram cell protein.

Each assay reported in this study was

performed in triplicate and repeated a minimum of three separate times.

Linear

regression analyses (Energraphic 3.0) were used to derive standard curves and analysis
of variance (ANOVA, both one-way and two-way) was used to determine the significance
among treatment groups (University SAS program). Significance was set at the 0.05
level. Multiple comparison tests (BON, TUKEY, REGWF, REGWQ) were used for
comparing means of more than two groups.
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RESULTS

I. M O RPHO LO G Y O F H EA R T V A LVE LEAFLETS:

Histology.

The matrix collagen / proteoglycan and fibroblast cell population illustrated in Fig
2 is representative of histological analyses of all fresh valve leaflets utilized in this study.
The average number of fibroblasts in aortic and pulmonary valves were 67.37+23.17
and 77.76+25.3 per HPF (high power field), respectively. The fibroblast cell densities
in aortic and pulmonary valves were not significantly different (P > 0.05).

The

morphological appearance of fresh valve leaflet (Fig. 2) revealed a significant presence
of endothelial cells on the surface of the valve leaflet.

Scanning Electron Microscopy.

Light microscopy is not an adequate means of assessing endothelial cell
populations of valve leaflet tissue because only those cells lying along the edge of the
preparation are visible. Hence, the absence of endothelial cells on a particular histology
preparation does not mean such cells are not on the surface of the tissue. Scanning
48
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Fig. 2: Histological evaluation of fresh heart valve leaflet tissue. Note the detached line
of endothelial cells along the right margin of the section. Matrix cells (fibroblasts) are
clearly visible within the collagen/proteoglycan matrix. Magnification: 40X.
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Fig. 3: Scanning electron micrographic evaluation of fresh heart valve leaflet tissue. Note
the typical appearance of the endothelial cells in this photograph. Magnification: 137X.
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electron microscopy is a more convenient means of assessing endothelial cell populations
since the orientation permits a "view" directly down onto the surface of the valve tissue.
Fig. 3 presents a scanning electron microscope photomicrograph of fresh heart valve
leaflet tissue. The photomicrograph shows the smooth appearance of the endothelial cells
covering the valve leaflet surface.

n. DEVELOPM ENT

O F ASSAY TO ASSESS CELLULAR V IA B IL IT Y

Assessment of the metabolic viability of the cellular component of valve leaflet
tissue involved the measurement of accumulation rates of an imino acid into the cellular
components of valve leaflet tissue. The test is quantifiable, measuring the accumulation
rates of radiolabeled proline into viable cells and/or incorporation into proteins being
synthesized by viable cells. Radiolabeled proline was used in this study as a diagnostic
marker for cellular metabolic viability because it is an imino acid and as such does not
compete with other amino acids during transport. Proline transport by mammalian cells
is mediated by an active transport process where metabolic energy is utilized to
concentrate proline to an intracellular concentration greater than its extracellular
concentration. With tissues, the assay is, of course, complicated by the need to correct
for cellular accumulation values with respect to the tissue accumulation values. Inulin
is a polysaccharide that is too large to be transported into cells, and thus has traditionally
been used to assess extracellular fluid space in tissue (Tripathi and Bhatngar, 1987).
Radiolabeled inulin was used to correct the proline accumulation data for contributions
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attributable to the extracellular tissue volumes.

I f inulin accumulation into the

extracellular space of tissue is simply due to diffusion, and the rate of diffusion should
be a linear function of the concentration of inulin and this accumulation, which does not
require metabolic energy, should not be inhibited by metabolic poisons. Validity of the
proline accumulation assay was demonstrated using several approaches.

Proline and Inulin Accumulation with Time.

Measuring long term accumulation of radiolabeled proline and inulin by valve
leaflet tissue sections revealed that inulin accumulation increased for approximately 30
minutes, reaching a maximum value of 2.0 nmole / mg tissue protein, and remained
fairly constant for the 180 minutes of incubation (Figure 4). Proline accumulation,
however, continued to increase over the 180 minutes allowed for the assay (Figure 4).
Indeed, at 180 minutes the valve leaflet tissue sections typically accumulated roughly six
times as much proline as inulin.

In order to determine whether or not the proline

accumulation represented proline incorporation into cellular protein, equivalent tissue
sections were incubated in radiolabeled proline and transfered to 10% trichloroacetic acid
(TCA) for 10 minutes prior to washing three times in phosphate buffered saline
supplemented with 1 mM non-radiolabeled proline.

As may be seen in Fig. 4, the

porcine heart valve leaflet tissue sections incorporated very little proline into TCA
insoluble materials (protein) i.e., after 180 minutes approximately 14% of the proline
accumulated into the heart valve leaflets was present in proteins.

52

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Fig. 4: Accumulation of radiolabeled proline (0.1 mM) and inulin (0.1 mM) and
incorporation of radiolabeled proline (0. Im M ) into trichloroacetic acid insoluble material
by porcine valve leaflet tissue. For the proline/trichloroacetic acid data, the valve leaflet
tissue sections were transfered to 10% TCA for 10 minutes prior to tissue solubilization
and counting. Data expressed as mean ± standard deviation.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

- -

00

<

CO
CO

\

<

•C M

o
- - LO

f—
cr

o

CL
CO

2

•C

<

- - CM

TIME (MINUTES)

CL
I—

_1
=3
2
I
ro

LU

O)

i—o —•

UJ

z:
o

CL
CL

o
in
—

CD

CD

ro

o

o

o

o

N B iO d d 3 flS S Il o n / 3 1 0 n u

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Proline and Inulin Accumulation Versus Concentration.

If proline accumulation by the tissue is attributable to cell membrane localized
transport systems and is due to active transport, proline accumulation should exhibit
saturation kinetics. Inulin accumulation, by the tissues, however, should be a linear
function of inulin concentration since inulin accumulation is a simple diffusion process.
Analyzing proline and inulin accumulation over concentration ranges of 0.1 to 1 mM,
it was determined that proline accumulation began to exhibit saturation at concentrations
in excess of 0.5 mM when velocities (nmole / mg tissue protein / minute) for each
proline and inulin concentration were taken. The rates of inulin accumulation, however,
were a linear function of inulin concentration (Fig. 5).

Effects of Preincubation of Tissue on Proline and Inulin Accumulation.

If the proline accumulation assay is indeed measuring metabolic viability of the
fibroblast cell population of the valve tissue, incubation of valve leaflet tissue sections
prior to a transport assay should not affect inulin accumulation but should reduce proline
accumulation if the treatment reduces cellular viability.

Porcine valve leaflet tissue

sections were therefore incubated in Eagle’s M EM at 4°C, for the times indicated, prior
to their transfer into Eagle’s M EM containing either radiolabeled proline or radiolabeled
inulin, and incubation for 180 minutes at 37°C. As may be seen from the data in Fig.
6, in vitro "cold ischemic time" resulted in a rather rapid loss in the ability of the tissue
54
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Fig. 5: Proline and inulin accumulation by porcine heart valve leaflet tissue
concentration of radiolabled substrates.
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Fig. 6: Proline and inulin accumulation (180min) by fresh porcine valve leaflet tissue
after storage in Eagle’s Minimum Essential Medium at 4°C for the times (in vitro cold
ischemic time) indicated. The error bars indicate standard deviation.
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sections to accumulate radiolabeled proline (consistent with a loss in cellular transport
activity), but tissue sections were not affected in their ability to accumulate radiolabeled
inulin (consistent with the suggestion that inulin accumulation is attributable to the
extracellular tissue volume).

In addition, the data suggests that incubation of tissue

sections in tissue culture medium at 4°C for 48 hrs reduced the ability of the cellular
population to accumulate proline to a level below the ability of the present assay to detect
activity.

Effects of Metabolic Poisons on Proline and Inulin Accumulation.

Metabolic poisons have traditionally been used to determine whether or not
accumulation of "nutrients" by cells is due to an "active" or "passive" transport
mechanism. It might therefore be suggested that proline, but not inulin, accumulation
by the valve leaflet tissue sections would be reduced in the presence of either sodium
azide or dinitrophenol - if the proline accumulation is due to the cellular component.
From data presented in Fig. 7 it may be seen that both sodium azide and dinitrophenol
dramatically reduced the ability of the valve leaflet tissue to accumulate proline (P
<0.05) , but not inulin (P > 0.05).

Indeed, dinitrophenol reduced the proline

accumulation to the level that the tissue was able to accumulate inulin, i.e., the
accumulation which is due to the extracellular matrix space of the tissue. Sodium azide
(Im M ) did not appear to completely block the ability of the cellular component of the
tissue to accumulate radiolabeled proline.
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Fig. 7: Effects of metabolic poisons on proline (O.lm M) and inulin (Q.lm M)
accumulation (180 minutes).

Sodium azide (Im M ) and dinitrophenol (Im M ) were

present in the transport medium during the transport assays. The error bars indicate the
standard deviation.
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Fig. 8: Proline (O.lmM) and inulin (O.lmM) accumulation (180 minutes) by aortic,
pulmonary, mitral and tricuspid valves. The error bars indicate the standard deviation.
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Proline and Inulin Accumulation by Other Valve Tissues.

Finally, it was of interest to determine whether tissue from pulmonary, aortic,
mitral, and tricuspid valves were equivalent in their ability to accumulate radiolabeled
proline and inulin. Provided these tissues were uniform with regard to their cellular
component, the tricuspid and or mitral valves could conceivably be used to assess proline
accumulation activity in the more clinically used aortic and pulmonary valves. Proline
and inulin accumulation by these four valve tissues were not significantly different (P
> 0.05, Fig. 8) and it is suggested that, provided the tissues are treated in a similar
manner, tissues from any valve may be used to assess proline accumulation activity for
the other valve tissues.

m. ASSESSMENT O F EFFECTS O F W A R M AND COLD IS C H E M IC

TIM ES ON

CELLULAR V IA B IL IT Y

Cryopreservation of heart valves involves a variety of steps and procedures. Each
step and procedure presents the potential for reduction of cellular vaibility.

Warm

ischemia has always been considered to reduce cellular viability in tissues and heart
valve allografts. Processing protocols in use around the world have varied markedly in
allowable warm ischemia intervals following death of the donor (Bodnar et al., 1989).
Warm ischemic time is defined as the time interval from cessation of donor heart beat
to initial cooling of valve tissue with cold saline. The focus of this portion of the study
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was characterization of the ischemic injury phase by examining the time dependent
progression of biochemical changes in porcine heart valve leaflets during the obligatory
warm ischemia following donor death. Because it was not possible to analyze the effects
of in vivo warm ischemia on metabolic viability of valve leaflet tissue, in vitro warm
ischemic effects were analyzed.

Data presented in Fig. 9 reveals that

proline

accumulation dimished with increasing time of ischemic injury. After as little as one
hour of warm ischemia the leaflet tissue was capable of accumulating 1.606 nmole
proline / mg tissue protein. This value fell to 1.28 nmole /mg tissue protein at 6 hours,
0.7 nmole /mg tissue protein at 12 hours, and 0.39 nmole / mg tissue protein at 24
hours. The inulin accumulation averaged approximately 0.3 nmole / mg tissue protein
irrespective of in vitro warm ischemic time, and represents passive accumulation into
extracellular space volume. Once proline accumulation falls to this "inulin level", the
cells may be considered to be metabolicly "dead", i.e ., measurable proline accumulation
falls to below detectable limits.

This reduction occured within 24 hours of post

harvesting in vitro warm ischemic time.

In vitro cold ischemic time is associated with transport of valve tissue from the
site of procurement to the site of processing and subsequent processing. Cold ischemic
time is defined as the time interval after transfer of the heart to cold washing and
transport solutions until the time of either cryopreservation or analysis for some variable.
As shown in Fig. 10, proline accumulation diminished as a function of the cold ischemic
time for heart valve leaflets held in Eagle’s Minimum Essential Medium (Eagle’M EM)
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Fig. 9: Proline (O.lmM) and inulin (O.lmM) (180 minutes) accumulation in
nanomoles/mg of porcine heart valve leaflet tissue protein at in vitro warm ischemic time
intervals of 1,6,12 and 24 hours. The error bars represent standard deviation.
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Fig. 10: Proline accumulation versus in vitro cold ischemic time. The porcine heart valve
leaflets were incubated at 4°C in Eagle’s Minimal Essential Medium and UW solution
for the times indicated. Tissue sections were then evaluated for proline accumulation for
180 minutes.

The error bars represent standard deviation (n = 3). The dashed line

indicates average inulin accumulation under equivalent assay conditions.
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or UW (University of Wisconsin) solution. At 72 and 96 hrs of cold ischemic time in
Eagle’s M EM , the porcine heart valve leaflets were only able to accumulate 10% as
much radiolabeled proline as compared to the "fresh", zero cold ischemic time, tissue.
In contrast, the proline accumulation dimished by approximately 60% after 24 hrs of
storage of valves in UW solution and this value remained constant at 1.1 nmole proline
/mg tissue protein for next 72 hrs assayed, i.e. after 96 hrs of storage in UW solution,
the valve leaflets were still able to accumulate approximately 40% as much proline as
could be accumulated by "fresh" valve leaflet tissue.

IV. ANTIBIOTIC DISINFECTION

It is not possible to assure that cardiovascular tissues obtained from donors, even
under "sterile" operating room conditions, are sterile after procurement and initial
processing. Many procurement groups, therefore, include an antibiotic disinfection step
in the tissue processing protocol. The purpose of this study was to find an antibiotic
disinfecting solution for cardiovascular tissues which would allow maximal cellular
viability while maintaining antimicrobial activity.

Effects of Antibiotics on Cellular Viablitv:

Accumulation of radiolabeled proline

by fresh valve leaflet tissue following

incubation in culture medium and culture medium supplemented with different antibiotics
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was used in this aspect of the study to assess the effects of antibiotics mediated tissue
disinfection on cellular viability. Table 1 lists the kinds and concentrations of antibiotics
used in this study.

Data shown in Fig. 11 reveal that incubation of porcine heart valve tissue in
RPMI 1640 tissue culture medium at 4°C resulted in a slow but steady decline in the
ability of that tissue to accumulate radiolabeled proline. After 24 hours of incubation,
the tissue had lost approximately 60% of its ability to accumulate proline and by 72
hours the tissue sections were only capable of accumulating approximately as much
proline as equivalent pieces of tissue were capable of accumulating inulin (dashed lines
in the figures), i.e., the tissue is metabolicly "dead" relative to the sensitivity of the
assay. Heart valve tissue sections incubated in RPMI 1640 medium supplemented with
all five antibiotics (solution A) were reduced in their ability to accumulate radiolabeled
proline by 80% at 24 hrs and 100% at 48 hrs.

Because it was recognized that one or more of the individual antibiotics may
represent a toxic element in solution A, various combinations of antibiotic solutions were
tested. Data from one such series are presented in Fig. 12. Omission of amphotericin
B from the total antibiotic mixture (solution A) resulted in heart valve leaflet tissue where
the ability to accumulate proline mimicked that of tissue incubated in the absence of
antibiotics, i.e. control medium

(P >0.05) . Incubation of tissue sections in

amphotericin B supplemented medium (Fig. 12) clearly resulted in cuspal tissue with
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Table 1: Composition of antibiotic mixtures used in valve disinfection
Composition
Antibiotic solution A

Antibiotic solution B

Antibiotic solution C

Concentrationfug/ml)

Amphotericin B

25

Cefoxitin

120

Lincomycin

100

Polymyxin B

50

Vancomycin

240

Cefoxitin

120

Lincomycin

100

Polymyxin B

50

Vancomycin

240

Penicillin

50U/ml

Streptomycin

1mg/ml

A ll antibiotics were dissolved in RPM I 1640 medium containing 10% fetal calf
serum. A ll antibiotic solutions were made fresh on the day they were used.
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Fig. 11: Proline (O.lmM) accumulation (180 minutes) by fresh porcine valve leaflet
tissue after storage in RPMI 1640 medium and RPMI 1640 medium supplemented with
antibiotic solution A

for the times indicated.

Data expressed as nmoles proline

accumulated per mg tissue protein. The dashed line represents average inulin (0. Im M )
accumulation over similar time intervals by porcine valve leaflet tissue.
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Fig. 12: Proline (O.lmM) accumulation (180 minutes) by fresh porcine heart valve tissue
after storage in RPMI 1640 medium, in RPMI 1640 medium supplemented with antibiotic
solution B, and in RPMI 1640 medium supplemented with amphotericin B alone for the
times indicated. Data expressed as nmoles proline accumulated per mg tissue protein.
The dashed line represents average inulin (0. Im M ) accumulation (180 minutes) at similar
experimental conditions by fresh porcine valve leaflet tissue.
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proline accumulation abilities similar to those incubated in medium supplemented with
all five antibiotics in solution A (Figure 11), i.e., amphotericin B was presumably
responsible for the greater reduction in proline accumulation ability by tissue incubated
in antibiotic solution A.

Amphotericin B alone in RPM I 1640 medium appeard to

reduce proline accumulation more than when amphotericin B was combined with the
other four antibiotics (cefoxitin, polymyxin B, vancomycin, and lincomycin) in solution
A.

These data suggest that the presence of the other four antibiotics may in some

manner reduce the toxicity of amphotericin B to the cells.

Because other groups use different antibiotic solutions in their sterilization
protocol (Stricken et al., 1983), the effects of penicillin and streptomycin (antibiotic
solution C) on proline accumulation were also examined. The data shown in Fig. 13
suggest that this antibiotic solution also dramatically reduced proline accumulation by
porcine heart valve tissue.

After as little as 3 hours of incubation in penicillin and

streptomycin, the ability of the tissue sections to accumulate proline was reduced by
40% (as compared to a 20% reduction in equivalent tissue incubated in medium alone).
There did not appear to be any further reduction in proline accumulation activity until
after 24 hours incubation in solution C. At that time, proline accumulation was roughly
reduced by 60% as compared to a 40% reduction in equivalent tissue sections incubated
in RPMI 1640 medium alone.

Studies involving incubation of heart valve tissue in

penicillin or streptomycin alone would suggest that the "toxicity" of these two antibiotics
may reside with streptomycin, since incubation in penicillin alone did not result in
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Fig. 13: Proline (O.lm M) accumulation (180 minutes) by fresh porcine valve leaflet
tissue after storage in RPMI 1640 medium and RPMI 1640 medium supplemented with
antibiotic solution C

for the times indicated.

Data espressed as nmoles proline

accumulated per mg tissue protein. The error bars indicate the standard deviation. The
dashed line represents average inulin (O.lmM) accumulation (180 minutes) by fresh
porcine valve leaflet tissue at equivalent time and treatment conditions.
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Fig. 14: Proline (O.lm M) accumulation (180 minutes) by fresh porcine valve leaflet
tissue after storage in RPM I 1640 medium and RPMI 1640 medium supplemented with
penicillin for the times indicated. The error bars indicate the standard deviation. The
dashed line represents average inulin (O.lmM) accumulation (180 minutes) by fresh
porcine valve leaflet tissue.
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Fig. 15: Proline (0.1 mM) accumulation (180 minutes) by fresh porcine valve leaflet
tissue after incubation in RPMI 1640 medium and in RPM I 1640 medium supplemented
with streptomycin. Data expressed as nmoles proline per mg tissue protein. The error
bars indicate standard deviation. The dashed line represents average inulin (O.lmM)
accumulation (180 minutes) by fresh porcine valve leaflet tissue.
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reduction of proline accumulation (P >0.05, Fig. 14).

The result in Fig. 15 also

supported this suggestion. The incubation of heart valve tissue in streptomycin alone for
over 24 hrs significantly reduced its ability to accumulate proline when compared to
proline accumulation in tissue incubated in medium without streptomycin (P <0.05).

Effectiveness of Antibiotic Disinfection:

The objective of this study was to demonstrate the effectiveness of antibiotic
solution A in killing anticipated microbial contaminants.

The study involved the

membrane filtration of the tissue culture media containing antibiotic solution A used in
tissue disinfection following incubation of a variety of bacterial species (E. coli, S.

aureus, S.

epidermidis, S. pneumoniae, C. petfringens, and S. faecalis ) in the

sterilization solution for varying periods of time. As may be seen in table 2, incubation
of the various bacterial species in the sterilization medium at 4°C for less than 12 hrs
yielded positive cultures when the filter membranes were incubated on agar plates of
Thioglycolate medium at 37°C.

Because the filters had been extensively washed to

remove residual antibiotic solution, the absence of growth on plates was taken to mean
that no viable bacteria were present on the filter. Where the bacteria were incubated for
either 24 or 48 hrs at 4°C in antibiotic solution A, no viable bacteria, except with

Streptococcus faecalis, were detected on the filters.
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Table 2: Disinfection Potential of Antibiotic Solution A on Bacterial Species
Bacterial Strains

Time of Incubation in Antibiotic Solution A at 4°C
0

6

12

24

48

E. coli

+

+

+

-

-

S. aureus

+

+

+

-

-

S. epidermidis

+

+

+

-

-

S. pneumoniae

+

+

+

-

-

C. perfringens

+

+

+

-

-

S. faecalis

+

+

+

+

Data indicated as " + " for positive bacterial growth on the filter or as

+

for

negative bacterial growth on the filter. Bacterial densities ranging from greater than one
million bacteria/ml to less than one bacterial/ml were tested in 1 to 10 dilutional series.
Growth from any dilution was indicated as positive.

74

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

V. TOXICITIES OF CRYOPROTECTANTS ON PORCINE HEART TISSUE

Effects o f Crvoprotectants on Cellular Viability:

Cryopreservative agents are essential in the long-term storage of transplantable
tissues by freezing (Graham, 1975). Me SO and glycerol are the most commonly
2

employed cryoprotective agents, and they have been shown to protect a variety of cells
from the damaging effects of freezing and storage at very low temperature (AshwoodSmith, 1975).

Disadvantages of the use of either MejSO or glycerol are that the

concentrations within the accepted useful range are not considered to be without toxic
effects, usually of a time/temperature-dependent nature (Graham,

1975).

An

investigation of the effects of M ^SO and glycerol on cellular viability in porcine heart
valve tissue was therefore undertaken using 3H-proline and 3H-inulin transport assays.
The objectives of the proline accumulation assays were to assess the effects of incubation
of valve tissue, in various concentrations of cryoprotective agents for a specified period
of time or in a given concentration of cryoprotective agents for variable periods of time
(at both 4°C and 37°C), on subsequent proline accumulation.

In the first series of variable-time experiments, incubation of valve tissue in

medium supplemented with 10% fetal calf serum and 10% MezSO at 4°C, resulted in
significant reductions in subsequent proline accumulation activity compared to similar
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tissue sections incubated in medium supplemented only with 10% fetal calf serum at 4°C
(Fig. 16, P < 0.05).

Equivalent assays performed at 37°C also revealed significant

differences in proline accumulation activities by heart valve tissue sections incubated in
the presence or absence of 10% N ^SO (Fig. 17, P <0.05).

Glycerol is still frequently used in cryopreservation protocols and thus the effects
of glycerol incubation were also examined. Incubation of valve cuspal tissue sections in
medium supplemented with 10% fetal calf serum and 15 % glycerol at either 4°C or 37°C,
resulted in a significant decrease in subsequent proline accumulation activity, i.e.,
approximately 60% reduction and 65% reduction after as little as 60 minutes at 4°C and
at 37°C, respectively. Equivalent tissue sections incubated in medium supplemented with
10% fetal calf serum alone at 4°C or 37°C were decreased in subsequent proline
accumulation activities by only 15% to 20% after 60 minutes incubation (Figs. 18 and
19, P < 0.05).

Experiments involving constant times of incubation (10 minutes) and variable
concentrations of Me SO or glycerol were performed to determine whether or not these
2

agents exhibited any concentration dependencies in toxicity (Figs. 20 and 21). The time
interval of 10 minutes for incubation was chosen for this study, because it represents that
time interval over which tissues to be cryopreserved in our laboratory have traditionally
been held for equilibration in medium plus 10% N ^SO prior to cryopreservation.
Following 10 minute incubations of tissue in increasing concentrations of cryoprotective
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Fig. 16: Proline (O.lm M ) accumulation (180 minutes) by fresh porcine valve leaflet
tissue sections after incubation in RPMI 1640 medium supplemented with 10% fetal calf
serum and in RPM I 1640 medium supplemented with 10% fetal calf serum and 10%
Me SO at 4°C for the times indicated. The error bars indicate standard error. The
2

dashed line represents average inulin (O.lm M) accumulation (180 minutes) by equivalent
fresh valve leaflet tissue sections.
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Fig. 17: Proline (O.lm M) accumulation (180 minutes) by fresh cuspal tissue sections
after incubation in RPM I 1640 medium supplemented with 10% fetal calf serum and in
RPMI 1640 medium supplemented with 10% fetal calf serum and 10% Me SO at 37°C
2

for the times indicated. The error bars indicate standard deviation. The dashed line
represents average inulin (O.lm M) accumulation (180 minutes) by equivalent fresh
porcine valve leaflet tissue sections.
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Fig. 18: Proline (0.1 mM) accumulation (180 minutes) by fresh cuspal tissue after
incubation in RPM I 1640 medium supplemented with 10% fetal calf serum and in RPMI
1640 medium supplemented with 10% fetal calf serum and 15% glycerol at 4°C for the
times indicated. The error bars indicate standard deviation of the mean. The dashed line
represents average inulin (O.lm M) accumulation (180 minutes) by equivalent fresh
porcine valve leaflet tissue sections.
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Fig. 19: Proline (0. Im M ) accumulation (180 minutes) by fresh porcine heart valve leaflet
tissue after incubation in RPMI 1640 medium supplemented with 10% fetal calf serum
and in RPMI 1640 medium supplemented with 10% fetal calf serum and 15% glycerol
at 37°C for the times indicated. The error bars indicate standard deviation of the mean
with n = 6.

The dashed line represents average inulin (O.lm M) accumulation (180

minutes) by equivalent fresh porcine valve leaflet tissue sections.
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and glycerol, they were transfered to proline transport medium and

allowed to accumulate radiolabeled proline (or inulin) for 180 minutes. The results (Figs.
20 and 21) suggest that incubation of valve leaflets in both MezSO and glycerol
concentrations greater than 5% results in a significant reduction in proline accumulation
when compared to control tissue (P < 0.05). However, none of the tissues incubated in
either of the various concentrations of Me SO or glycerol at 4°C for this time interval
2

exhibited proline accumulation activities significantly different from the tissue sections
incubated at 37°C (P > 0.05).

Osmolality studies:

In the osmolality studies, osmolality changes of the medium as a function of time
that the porcine aortic conduit tissue was incubated in RPMI 1640 medium supplemented
with 10% FCS and either 10% Me SO or 15% glycerol were assessed. As described in
2

the Materials and Methods section, the volumes of the tissue were determined by volume
displacement and the tissues were placed in RPM I 1640 medium supplemented with 10%
FCS and either 10% M e^O or 15% glycerol at both 4°C and 37°C. At specific time
intervals, aliquots of the solution were taken and osmolality values were determined. As
may be seen in Fig. 22, the osmolality of the medium gradually decreased over 80
minutes with a rate of change of -1.533 mOsm / kg H20 / minute at 4°C and -1.671
mOsm / kg H20 / minute at 37°C. Similar results were observed for 15% glycerol. As
may be seen in Fig 23, the osmolality of the medium also gradually decreased with a rate
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Fig. 20: Effects of variable concentrations of MezSO on subsequent proline (0. lm M )
accumulation (180 minutes). Proline accumulation by fresh porcine heart valve leaflet
tissue was assayed after incubation in RPMI 1640 medium supplemented with 10% fetal
calf serum and various concentrations of MezSO at 4°C and at 37°C for 10 minutes. The
error bars indicate standard deviation of the mean with N = 9 . The dashed line represents
average inulin (0,1 mM) accumulation (180 minutes) by equivalent fresh porcine valve
leaflet tissue.
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Fig. 21: Effects of variable concentrations of glycerol on subsequent proline
accumulation. Proline accumulation by fresh porcine heart valve leaflet tissue sections
was assayed after incubation in RPMI 1640 medium supplemented with 10% fetal calf
serum and various concentrations of glycerol at 4°C and at 37°C for 10 minutes. The
error bars indicate standard deviation of the mean with N = 6 . The dashed line represents
average inulin accumulation by equivalent fresh cuspal tissue.
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of change of -2.576 mOsm / kg H20 / minute at 4°C and -2.672 mOsm / kg H20 /
minute at 37 °C. For glycerol, the osmolality changes of the medium at 37°C were more
pronounced than at 4°C, b u t n o t f o r Me2SO.

Quantitation of MeJSO and Glycerol in Tissue:

In development of freeze-thawing protocols utilizing M e^O and glycerol, it is
advantageous to determine the distribution of the cryoprotectant within the tissue samples,
especially in relatively bulky tissues as a

function of time.

The time course of

penetration of the cryoprotectants into tissue prior to freezing can greatly influence the
design of the cryopreservation method.

It is critical that sufficient cryoprotectant

penetrates into the tissue prior to freezing.

Therefore, the penetration rates of both

M e^O and glycerol into the porcine aortic conduit tissue were determined using HPLC
and a Refractometer respectively.

Fig. 24 shows a typical chromatogram for RPMI 1640 medium supplemented
with 10% FCS.

Extracts of the medium displayed one prominent peak with a retention

time of 1.82 minutes. Fig. 25 is a representative chromatogram for a sample of RPMI
1640 medium treated identically except that the medium contained 11 mg/ml Me2SO as
well as 10% FCS. The Methanol extracts of this mixture resulted in two peaks of 214
nm absorbing materials, one at 1.82 minutes, and a second at 3.37 minutes suggesting
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Fig. 22: Osmolality change of the medium as a function of times that the porcine aortic
conduit tissue was incubated in RPM I 1640 medium supplemented 10% FCS and 10%
MejSO (1.4M ) at both 4°C and 37°C. Data expressed as mOsm / kg H20 . The error
bars indicate range.
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Fig. 23: Osmolality change of the medium as a function of times that the porcine aortic
conduit tissue was incubated in RPM I 1640 medium supplemented with 10% FCS and
15% glycerol (2 M ) at 4°C and 37°C. Data expressed as mOsm /kg H20 . The error
bars indicate the range.
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Fig. 24: Typical chromatogram for methanol extracted R P M I1640 medium supplemented
with 10% FCS. The sample was diluted 1:200 with 10% methanol, centrifuged in a
microfuge for 5 minutes and filtered prior to injection. A sample volume of lOul was
injected and absorbance of the eluent was monitored at 214nm.
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Fig. 25: Typical chromatogram for methanol extracted RPMI 1640 medium (with 10%
FCS) plus 11 mg / ml h ^ S O .

The sample was diluted 1:200 with 10% methanol,

centrifuged in a microfuge for 5 minutes and filtered prior to injection.

A sample

volume of 10 ul was injected and absorbance of the eluent was monitored at 214nm.
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that M ^SO can be effectively resolved from potential eluents found in RPM I 1640
medium.

Data plots of Me SO chromatograph peak areas versus the concentration of
2

Me SO were linear with ^ = 0 .9 9 (Fig.26). These data indicated that a standard curve
2

could be used for determination of Me SO concentrations between 1.1 mg / ml and 11
2

mg / ml in the tissue samples.

RPMI 1640 medium amended with 10% MezSO and with 10% FCS is most
commonly used in cryopreservation of allograft heart valve.

Determination of the

concentration and time requirements for Me SO to enter and reach equilibrium within the
2

tissue prior to cryopreservation is essential. Fig. 27 shows the concentrations of Me^SO
in porcine conduit tissue as a function of time of exposure of conduit tissue to 10%
Me SO (1.4M ) at both 4°C and 37°C. The results revealed that the kinetics of Me SO
2

2

penetration into the tissue display a biphasic nature, with an initial rapid influx for the
first 20 minutes (with a penetration rate of 17.85 mM /minute at 4°C, and a penetration
rate of 19.75 mM /minute at 37°C), followed by a slower rate after approximately 20
minutes (with a penetration rate of 6.65 mM /minute at 4°C, and a penetration rate of
7 mM /minute at 37°C).

After 80 minutes, the concentration of Me SO reached an
2

equilibrium between the tissue and the bathing medium. The penetration, i.e., "tissue
loading", of M e^O st 4°C is slightly less that at 37°C (P < 0.05). At equilibrium, the
concentrations of Me SO in the conduit tissues were 0.6M and 0.8M at 4°C and 37°C,
2

89
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Fig. 26: Plot of M ^SO chromatographic peak area versus the concentration of Me SO.
2

Me SO was prepared as described in the Materials and Methods. The 11 mg / ml Me^SO
2

stock solution was then diluted with RPMI 1640 medium (with 10% FCS) to give a series
of standards ranging in MezSO concentration from 1.1 to 11 mg / ml MezSO.

All

samples were then diluted 1:200 with 10% methanol and centrifuged in a microfuge for
5 minutes and filtered prior to injection.

The chromatographic peak area is plotted

against the concentration of MezSO in the methanol-diluted samples.
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Fig. 27: Concentration of Me SO in porcine aortic conduit tissue as a function of time
2

of incubation in RPMI 1640 medium supplemented with 10% FCS and 10% (1.4M )
Me SO at 4°C and 37°C. Tissue samples were prepared and processed as described in
2

the Materials and Methods section.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CM

I—
3
O

-- o

o
o
Ld

2
O
(Z

Q_
2

"" CO

CM

Ld

o

00

CO

CM

^ o
o

(W) O S ^ R JO N0 11VJiN 30 N0 0

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TIME (MINUTES)
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respectively. The concentrations of N ^SO in the aortic conduit tissue did not correlate
with the expected concentration (1.3 M ) based on dilution by tissue volume suggesting
that Me SO did not distribute into the conduit tissue evenly. This information is crucial
2

for the design of human tissue cryopreservation protocols in that it permits some estimate
of the time required for the tissues to become equilibrated with MejSO in the bathing
solutions.

In the United Kindom, Donald Ross uses 15% glycerol for his cryoprotectant in
heart valve cryopreservation (Ross, 1985). Therefore, the rate of glycerol penetration
into aortic conduit tissue was measured using a Refractometer. Plots of the refractive
index of glycerol in RPMI 1640 medium supplemented with 10% FCS versus
concentrations of glycerol in RPM I 1640 medium supplemented with 10% FCS were
found to be linear (^ = 0 .9 6 , Fig 28). The concentrations of glycerol in porcine aortic
conduit tissue as a function of time of tissue exposure to 15% glycerol (2 M ) at both 4°C
and 37°C are shown in Fig 29. The concentration of glycerol in conduit tissue gradually
increased with increasing time of incubation.

The results also revealed biphasic

characteristics with an initial rapid influx for the first 20 minutes (with a penetration rate
of 29.9 mM /minute at 4°C, and a penetration rate of 41 mM /minute at 37°C), followed
by a slower influx for next 40 minutes (with a penetration rate of 6 mM /minute at 4°C,
and a penetration rate of 9 mM /minute at 37°C). At 60 minutes, the concentration of
glycerol reached an equilibrium between the tissue and the bathing medium and the
equilibrium concentrations of glycerol in conduit tissue were 1.0M and 1.2M at 4°C and

92
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Fig. 28: Standard curve of glycerol concentration versus refractive index. The glycerol
stock solution was diluted with RPMI 1640 medium supplemented with 10% FCS to give
a series of standards ranging in glycerol concentrations between 0.0013 M to 0.13 M .
The refractive index was measured using a refractometer as described in the Materials
and Methods section.
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Fig. 29: Concentration of glycerol in porcine aortic conduit tissue as a function of time
of incubation in 15 %glycerol (2 M) at 4°C and 37°C. Tissue samples were prepared and
processed as described in the Materials and Methods section.
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37°C, respectively. The concentration in the aortic conduit tissue at the equilibrium did
not correlate with the expected concentration (1.85 M ) when tissue was incubated at 4°C
and 37°C based on dilution by tissue volume.

VI. STORAGE

Cryopreservation of human heart valves has become widely accepted as the
preferred method for preservation of aortic and pulmonic valves used in valve
replacement therapy. Numerous groups are now procuring and freezing valves prior to
storage in the vapor phase of liquid nitrogen (-130PC to -196°C) or directly in liquid
nitrogen (-196°C).

Storage of valves in the vapor phase of liquid nitrogen requires

frequent replenishment of liquid nitrogen either manually or with sensing devices which
automatically refill the chamber when the liquid nitrogen falls below a prescribed level.
During refilling with liquid nitrogen the valves may become submerged, resulting in a
rapid reduction in temperature. SEM was used to evaluate whether this rapid reduction
in temperature would be harmful to the valves.

Valves utilized in this study were

procured and processed by the staff of LifeNet-Virginia Tissue Bank using procedures
described in the Materials and Method section. Briefly, human valves were procured
within 6 hrs of death and controlled-rate frozen in RPMI 1640 medium supplemented
with 10% fetal calf serum and 10% Me SO. A freezing rate of -l°C/minute to -80°C was
2

employed with the frozen valves being subsequently placed into appropriate boxes and
transfered to a liquid nitrogen vapor storage tank where the temperature of storage was
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approximately -150°C. Valves were removed from storage and immediately submerged
into liquid nitrogen for 5 minutes, removed and returned to a liquid nitrogen "dry
shipper" (-150°C) and held until thawing. The valves were quickly thawed at 42°C (less
than 3 minutes thawing time), fixed, and used for the SEM study.

Representative SEM photomicrographs of the surfaces of cryopreserved heart
valve cuspal tissue sections which were stored in liquid nitrogen vapor phase, but not
submerged in liquid nitrogen, are shown in Figs. 30a-30b. A total of seven valves were
examined in this manner and the photographs shown in Fig. 30 are representative of the
observations for all of these valve tissues.

The surfaces of cryopreserved leaflets

typically lacked a significant covering of endothelial cells, although small patchy areas
of endothelial cell coverage were found and a relatively smooth "basement" membrane
is clearly visible.

Figs. 3 la-3 lb are representative SEM photomicrographs of cryopreserved valve
leaflets, which have been immersed in liquid nitrogen.

The photographs taken at

relatively low magnification (57.5X) revealed fractures that penetrated into the underlying
collagen/proteoglycan matrix.

The fractures shown in Fig. 31b were extensive and

frequently accompanied by parallel fractures of similar size and character.

At even

higher magnifications (Fig 32a), the surface could be observed to be highly disrupted
by the presence of irregular breaks.

These breaks were apparently not due to

fixation/dehydration because they did not appear in the vapor-stored valves. Examination
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Fig. 30 a-b: Scanning electron photomicrograph of human heart valve tissue from a
cryopreserved valve which was not submerged in liquid nitrogen. The magnifications
for 31a-b are 237-243 X.
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Fig. 31 a-b: Scanning electron photomicrograph of human heart valve leaflet tissue from
cryopreserved valves which were submerged in liquid nitrogen for 5 minutes. The
magnification of 31a is 57.5 X and the magnification for 31b is 242 X.
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of fractures as shown in Figure 31b at higher magnification (873X, Fig 32b) revealed
that the fractures disrupt the underlying collagen/proteoglycan matrix. The "break" in the
tissue is relatively "clean" and "sharp", suggesting a fracture of the tissue rather than a
tear (which might occur with tissue contractures associated with improper tissue
preparation). Figure 33a-33b show that the fracture lines typically run perpendicular
to the orientation of the underlying collagen fibers (perpendicular in fig 33a) and appear
to cut across the underlying collagen fibers (fig 33b).

Figure 34 represents the temperature profile of a typical valve cryopreserved in
tissue culture medium amended with 10% Me SO, such that the total volume of frozen
2

material constituted 100 mis, immediately after immersion into liquid nitrogen. The
temperature probe from a Cryomed Controlled Rate Freezer was placed in close
proximity to the leaflet tissues of the valve and temperatures, consistent with limitations
imposed by the invasive nature of the temperature probe, in this region were measured.
As may be seen in figure 34, the temperature within the probe region dropped within 2.5
minutes from -130°C to -196°C for an "average" temperature change of 26.4°C/minute.
It is important to note that this temperature change is not uniform for the entire volume
of the valve package and that material near the surface of the bag cools more rapidly than
material in the bag interior. These differences may be important to the introduction of
fractures in tissues frozen in these matrices in that these temperature differentials may
create stress within the solid matrix of the frozen material.
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Fig. 32 a-b: Scanning electron photomicrograph of human valve leaflet tissue from
cryopreserved valves which were submerged in liquid nitrogen for 5 minutes. The
magnifications of 32a-b are 873X.
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Fig. 33a-b: Scanning electron photomicrograph of human heart valve leaflet tissue from
cryopreserved valves which were submerged in liquid nitrogen fof 5 minutes.

The

fracture lines typically run perpendicular to the orientation of the underlying collagen
fibers (perpendicular in Fig. 33a) and cut across the underlying collagen fibers (Fig.
33b). The magnification of 33a is 604 X and the magnification of 33b is 190 KX.
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Fig. 34: Temperature, in degree centigrade, in close proximity to the valve leaflets
a function of time.
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V n. THAWING AND REMOVAL OF CRYOPROTECTANTS

Preparing the frozen allograft for transplantation involves thawing of the tissue
at a specific rate and removal of cryoprotective agents from the thawed tissues. Several
different protocols for thawing the allograft and diluting out the cryoprotectant have been
developed by Karp, Angell and Kirklin (Karp, 1986; Angell, 1987; Kirklin, 1987).
These techniques involve the immersion of the frozen allograft in a specified volume of
solution at 37°C or 42°C. Following completion of thawing, valves were removed from
their freezing pouchs and through a step-wise dilutional process, the tissue was returned
to an "isotonic state". The isotonic solutions used w ill, presumably, gradually allow the
dehydrated cryopreserved cells or tissues to reestablish osmotic equilibrium and
rehydrate. The step by step dilutional protocol was reported to increasingly dilute out
the cryoprotectant employed in the freezing solution such that minimal damage occured
to the cellular population of the valve.

This portion of this study was designed to

determine the optimal thawing rate for the tissue and monitor the concentrations of
cryoprotectants in the heart valve tissue during each step-wise dilutional step in order
to avoid potentially damaging osmotic stress to the cells.

Determination of Optimal Thawing Rate:

The determination of optimal thawing rate utilized porcine heart valve fibroblasts
(PHVF) grown in tissue culture as a model for assessing the relative sensitivity of heart
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valve fibroblasts, present in the tissues, to thawing. PHVF cells grown in tissue culture
were frozen in R P M I1640 medium supplemented with 10% fetal bovine serum and 10%
Me SO as described in the Materials and Methods and stored at -150°C in an ultralow
2

freezer. Aliquots were thawed at different temperatures (4°C, 20°C, 37°C, 42°C, and
75°C) such that different thawing rates were obtained. As shown in table 3, it required
70, 35, 2.5, 2, and 1.5 minutes to thaw the PHVF cells at 4°C, 20°C, 37°C, 42°C and
75°C, respectively. The calculated thawing rates were 2.14, 4.28, 60, 75, and 100°C /
minute for the thawing temperatures of 4, 20, 37, 42, and 75°C, respectively. Thawing
at 37 and 42°C resulted in the least number of dead cells (9.3±4.5 and 9.7+ 3 %),
whereas thawing at 4, 20, 75°C resulted in 26+8.6, 28+6.4, 17±2 % dead cells. The
number of "dead" cells thawed at 37°C and 42°C were significantly lower than those
cells thawed at 4°C, 20°C and 75°C (P <0.05). The number of dead cells thawed at
37°C and 42°C were not significantly different (P > 0.05).

Determination of Cryoprotectant Concentration in the Tissue at Each Step in the StepWise Dilutional Process:

An investigation of cryoprotectant (both glycerol and MejSO) concentrations in
the thawed porcine aortic conduit tissue at each step in the step-wise dilutional process
were performed. The step-wise dilutional procedures used to dilute the cryoprotectants
in this study mimiced the procedures used for preparation of transplanted valves by LNVTB. Briefly, porcine aortic conduit tissues (approximately 5 grams) were immersed in
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Table 3: Viability of Porcine Heart Valve Fibroblasts Thawed at Variable Rates of
Temperature Change

Temperatures Thawed (°C)

4

20

37

42

75

Length of Time Required for

70

35

2.5

2

1.5

2.14

4.28

60

75

100

26+

28 ±

9 .3 +

9 .7 ±

17+

8.6

6.4

4.5

Thawing (Minutes)
Thawing rate
(0°C / minutes)
Percentage of Dead Cells (%)

3

2

During the thawing procedures, 5 separate Cryogenic vials were thawed in water
baths at 4°C, 20°C, 37°C, 42°C, 75°C, respectively.

Once the cells were thawed

completely (by visual inspection), they were stained with trypan blue dye (0.4% trypan
blue in Dulbecco’s Phosphate Buffer Saline). The cells were counted in a hemocytometer
where cells staining blue were considered metabolically "dead" and their number added
to the number of "clear" cells ((i.e. living cells), to determine total cell number to get
the percentage of "dead" cells. Each assay was performed with three vials and three
separate experiments. The time required to thawed the cells in each vial was recorded
and used to calculate the thawing rate.
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45 ml RPMI 1640 medium containing 10% FCS

and either 10% Me SO or 15%
2

glycerol at 37°C for 120 minutes to allow the equilibration of the cryoprotectants between
the conduit tissue and bathing medium. Then 16.5 ml of RPMI 1640 medium containing
10% FCS was added to the aortic conduit tissue soaking in 45 ml RPM I 1640 medium
containing 10% FCS and 10% Me SO or 15% glycerol for 1 minute, The effective
2

concentrations of MezSO and glycerol in the medium were reduced from 10% and 15%
to 7.5 % and 10%, respectively. Then 33 ml of the same medium was added to the aortic
conduit tissue soaking in 61.5 ml RPMI 1640 medium supplemented with 10% FCS and
10% glycerol or 7.5% Me SO for 1 minute. At this step, the concentrations of Me^SO
2

and glycerol were reduced from 7.5% to 5% (for M e^O ) and 10% to 7.5% (for
glycerol). Finally, by adding an additional 100 ml of RPMI 1640 medium supplemented
with 10% FCS for 1 minute, the concentrations of MejSO and glycerol were finally
reduced to 2.5% and 5%, respectively.

The aortic conduit tissue was transfered to

RPMI 1640 medium supplemented with 10% FCS and held for an additional 80 minutes.
At each specific dilution step, conduit tissue was taken out of the medium quickly blotted
to remove excess fluid, and transfered to 10% methanol (for Me^SO) or RPMI 1640
medium supplemented with 10% FCS (for glycerol) for at least 24 hrs.

The

concentrations of Me SO and glycerol in the conduit tissue after each dilution step were
2

determined using an HPLC or a refractometer, respectively.

The concentrations of Me SO in the aortic conduit tissue after each step dilution
2

are shown in Fig.35, the concentration of MezSO reduced approximately 30% after the
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Fig. 35: Concentrations of N ^S O present in the aortic conduit tissue at each step of the
dilution process used to reduce M ^SO levels in clinically usable tissues. Concentrations
of Me SO were determined using a high performance liquid chromatography. The tissue
2

samples were prepared and processed as described in the Materials and Methods section.
"A" designates concentration of MejSO in porcine aortic conduit tissue when the tissue
was incubated in 10% Me SO. "B" designates the concentration of MejSO in porcine
2

aortic conduit tissue when the tissue was incubated in 7.5% Me^SO for 1 minute. "C"
designates concentration of MejSO in porcine aortic conduit tissue when the tissue was
incubated in 5% Me SO for 1 minute. "D" designates concentration of Me SO in porcine
2

2

aortic conduit tissue when the tissue was incubated in 2.5% Me^SO for 1 minute. After
the porcine aortic conduit tissue was diluted in 2.5% Me SO for 1 minute, the tissue was
2

transfered to RPM I 1640 medium supplemented with 10% FCS and incubated for an
additional 80 minutes.
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HPLC ANALYSIS OF Me2SO IN PORCINE CONDUIT

TIME (MINUTES)

Fig. 36: Concentrations of glycerol in aortic conduit tissue at each step of the dilution
process used to reduce glycerol levels in clinically usable tissues. Concentrations of
glycerol in the tissue were determined using a Refractometor. The tissue samples were
prepared and processed as described in the Materials and Methods section.

"A"

designates the concentration of glycerol in aortic conduit tissue when the tissue was
incubated in 15 % glycerol. "B" designates the concentration of glycerol in aortic conduit
tissue when tissue was incubated in 10% glycerol for 1 minute.

"C" designates the

concentration of glycerol in aortic conduit tissue when tissue was incubated in 7.5%
glycerol for 1 minute.

"D" designates the concentration of glycerol in aortic conduit

tissue when tissue was incubated in 5% glycerol for 1 minute. After the aortic conduit
tissue was incubated in 5% glycerol for 1 minute, the tissue was then transfered to RPMI
1640 medium supplemented with 10% FCS and incubated for an additional 80 minutes.
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three successive steps of dilution. With continuous incubation in RPMI 1640 medium
supplemented with 10% FCS (without Me SO), the concentration of Me SO was reduced
2

2

to 0.25 M after a total of 43 minutes of dilutional time (40 minutes in RPMI 1640
medium supplemented with 10% FCS without MeaSO) and this value remained fairly
constant for over 80 minutes.

When equilibrium has reached, the concentration of

MezSO in the aortic conduit tissue was 0.25 M .

The concentrations of glycerol in the aortic conduit tissue after each step dilution
are shown in Fig. 36, the concentration of glycerol decreased form 1.2 M to 0.6M after
three succesive steps of dilution. The concentration of glycerol was further decreased
to 0.2M after a total 43 minutes of dilution time (40 minutes in RPMI 1640 medium
supplemented with 10% FCS without glycerol) and this value remained constant over the
next 60 minutes. These results suggested that the present protocol is not effective in
removing all Me SO or glycerol from the allograft tissue prior to transplantation.
2

V m . A LK A LIN E PHOSPHATASE STUDY

Valve calcification is generally considered as the single most important cause of
valve dysfunction (Gallucci, et al., 1986; Milano, et al., 1984). This portion of the
research is based primarily on the suggestion that osteoinduction is responsible for the
process of bone regeneration after the implantation of demineralization bone grafts. It
is suggested that a similar process may occur following the transplantation of allograft
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heart valves.

This part of the study was designed to assess the osteoinductivity of heart

valve tissues and included the establishment of a porcine fibroblast cell line and its use
in an in vitro quantitative assay to assess the potential osteoinductivity of heart valve
tissue in vivo.

Characterization of the Porcine Fibroblast Cell Line:

Morphology. When viewed under the light microscope, porcine heart valve fibroblast
(PHVF) cells exhibited the spindle shapes characteristic of fibroblastic cells (Fig. 37a).
The pale-staining cytoplasm of the porcine fibroblasts extended irregularly from around
the nuclei, which were more or less flattened ovoid structures. Figure 37b illustrates
the distribution of PHVF at confluence, at which time cytoplasmic granules were more
clearly visible.

When PHVF cells were cultured in the presence of 0.2 gram wet weight of
minced porcine heart valve tissue, the cells appeared to become smaller and thinner (Fig
38a & b). Some granules and vacuoles surrounding the cells could be seen. Fig. 38b
illustrates the distribution of PHVF in the presence of 0.2 gram wet weight of minced
heart valve tissue at confluence.

Growth Curve. A typical growth curve of mammalian cells in culture consists of a lag
phase , a log phase and a plateu phase. The lag phase is an indication of the adaptability
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Fig. 37: Photographs of porcine heart valve fibroblast (PHVF) cells cultured in alpha
Minimum Essential Medium supplemented with 10% fetal calf serum. Passage 4. The
photograph in Fig. 37a represents the PHVF cells on day 4. The photograph in Fig. 37b
represents the PHVF cell on day 8

when cells had approached confluence.

Magnification: 100X.
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Fig. 38: Photographs of PHVF cells cultured in alpha Mimimum Essential Medium
supplemented with 10% fetal calf serum in the presence of 0.2 grams heart valve tissue.
The photograph in Fig. 38a represents PHVF cells on day 4. The photograph in Fig.
38b represents PHVF cells on day 8 when cells reached confluence. One piece of heart
valve tissue could be seen on the right bottom comor of the photograph in Fig. 38a. One
piece of heart valve tissue could be seen along the left bottom comer of the photograph
in Fig. 38b. Magnification: 100X.
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of cells to the culture environment.

The log phase indicates a steady-state growth

capacity. Population doubling time , a specific parameter for each individual cell line,
may be determined during the log growth phase. The plateau phase provides a measure
of the terminal density of the fibroblastic cell population. The porcine heart valve leaflet
fibroblasts were seeded into T-25 tissue culture flasks at 16000 cells /cm2 and maintained
in the indicated culture conditions. At each successive time interval, 3 flasks of cells
were harvested by trypsinization and counted with a hemacytometer. The porcine heart
valve fibroblast cells reached the plateau phase on day 8 and the terminal density was
3X106 cells / flask (1.2X105 per cm2). The lag phase was 4 days followed by 3 days of
logarithmic phase before reaching the plateau. Confluence of cell cultures were typically
observed after eight days in culture.

The

population doubling time for porcine

fibroblasts is approximately 36 hours (Fig. 39).

Characterization of Alkaline Phosphatase Kinetics.

The kinetics of alkaline phosphatase activity (AP) from PHVF cell extracts were
determined by assaying the enzyme activities at different substrate concentrations. The
reaction rates (unit/g cell protein) were plotted versus the substrate concentrations to
generate the Michaelis-Menten kinetics curve (Fig.41). This curve exhibits a classical
pattern for an enzyme with a rapid linear early phase, a slower intermediate phase and
a saturation phase (i.e., hyperbolic characteristics). The specific Vmax and Km values
were derived from a double reciprocal plot of the data (Fig. 42).

The Km value
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Fig. 39: Growth curve of porcine heart valve fibroblasts. Cells were seeded at 4X105
cells / 25 cm2 into a T-25 tissue culture flask containing 5 ml of alpha Minimum
Essential Medium supplemented with 10% FCS.

Population doubling time (TD)

calculated during log-phase of growth is approximately 36 hrs. The error bars represent
standard deviation.
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Fig. 40: Standard curve of absorbance, at 405 nm, versus concentration of p-nitrophenol
(PNP).

Authentic PNP was dissolved in 0.15 M 2-amino-2-methyl-l-propanol

(pH = 10.4) buffer solution as standards and their absorbances at 405nm were determined.
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Fig. 41: Michaelis-Menten kinetics of alkaline phosphatase extracted from PHVF cells.
Cells were extracted and alkaline phosphatase activities assayed on the day when cells
reached confluence.
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calculated from the data was used to determined the standard, or optimal, substrate
concentration to be used in subsequent alkaline phosphatase assays. The Vmax and Km
values for AP enzyme activity from porcine heart valve fibroblast cells were 0.028 unit
/ g and 0.36 mM, respectively.

AP Activity as a Function of Amount of H V Tissue in Culture Flasks:

This study was performed to determine the optimal amount of heart valve tissue
to be added to the culture flasks. PHVF cells were cultured in the presence of 0.1, 0.2,
0.3, 0.5 grams of heart valve tissue sections per T-75 flask with alpha Minimum
Essential Medium supplemented with 10% FCS, respectively (The cell seeding density
was approximately 2X106 cell per T-75 flask). AP activities were assayed when cells
reached confluence (Fig 43). AP activities in the groups (0.2 gram and 0.3 gram) were
2.4 and 2.55 unit / g cell protein, respectively, which were significantly higher (P
< 0.05) than the control group, i.e., PHVF without H V tissue (1.3 unit / g cell protein).
However, there was no significant difference amoung the control (1.3 unit / g cell
protein), 0.1 gram (1.75 unit / g cell protein), and 0.5 gram (1.5 unit / g cell protein)
groups (P > 0.05). Therefore, it was decided that 0.2 gram of heart valve tissue be the
standard quantity of tissue to be used in the later experiments.
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Fig. 42: Double reciprocal plot for alkaline phosphatase derived from porcine heart valve
fibroblasts.
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Fig. 43: AP activities of PHVF cells exposed to 0.1, 0.2, 0.3, 0.5, grams of heart valve
tissue. The AP activities were assayed on the day of confluence.

2X106 cells were

seeded per 75 cm2 in a T-75 flask with alpha Minimum Essential Medium supplemented
with 10% FCS. The error bars indicate standard deviation.
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AP Activities As a Function of Incubation of HV Tissue in Culture Flasks:

The purpose of this study was to determine the levels of alkaline phosphatase
activities in PHVF cultures as a function of time of culture in the presence and absence
o f heart valve tissue. PHVF cells (both in the presence of 0.2 gram of heart valve tissue
and absence of heart valve tissue) in T-75 tissue culture flasks reached visual confluence
on day 8 of culture.

As shown in Fig. 44, in the absence of heart valve tissue, AP

activities remained constant at approximately 1 unit / g cell protein until day 8 of culture.
In the presence of 0.2 grams of minced heart valve tissue, the AP activties gradually
increased over the time interval assayed. On days 8, 9, and 10, the AP activities were
approximately six fold higher than that activity on day 2 (P < 0.05). AP activities in the
experimental group (with the heart valve tissue in the culture flask) were significantly
higher than the control group (without heart valve tissue) between day 6 to day 10 (P
< 0.05).

Therefore, the time when the PHVF cells reached visual confluence was

chosen as the time for AP assays in the later experiments.

Effects of Variously Processed Heart Valve on AP Activities:

The objective of this study was to evaluate the osteoinductivity of variously
processed heart valve tissues, such as the heart valves with prolonged in vitro warm
ischemic time (W IT), in vitro cold ischemic time (C IT), and post-antibiotic treatment.
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Fig. 44: AP activities of PHVF during 10-days of incubation in the absence or presence
of 0.2 gram fresh porcine heart valve tissue. The cells reached confluence on day 8
when 2 xlO6 cells were seeded per 75 cm2 in a T-75 flask with Alpha Minumum
Essential Medium supplemented with 10% FCS.

The error bars indicate standard

deviation.
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The first set of experiments was to assess the effect of in vitro W IT of porcine
heart valve tissue on induction of AP activity in the cultured PHVF cell culture. Heart
valve tissue sections which had been incubated in Eagle’s Minimum Essential Medium
(Eagle’s M EM ) at 37°C for 24 hrs (0.2 gram) were added to each tissue culture flask
containing 106 cells / T 75 cm2 flask with 30 ml alpha Minimum Essential Medium
supplemented with 10% FCS.
confluence.

AP activities were measured when the cells reached

As shown in Fig. 45, AP activities in the experimental group (in the

presence of 0.2 gram of heart valve tissue with 24 hrs W IT) was significantly higher than
the control group (in the presence of fresh heart valve tissue sections, i.e. W IT = 0 hrs)
(P < 0.05). Both groups of tissue had similar cold ischemic times during procurement
and transport.

The second set of experiments were to evaluate the effects of C IT of porcine heart
valve tissue on induction of AP activities in cultured PHVF cell cultures. PHVF cells
were cultured with 0.2 gram heart valve tissue sections with zero hour of W IT and 24,
48, and 72 hrs of in vitro C IT (i.e., the fresh porcine heart valve tissue sections had
been incubated in Eagle’s Minimum Essential Medium at 4°C for 24, 48, 72 hrs). AP
activities were assayed when the cells reached visual confluence. As shown in Fig 46,
AP activities were significantly higher in the groups of PHVF cells that were cultured
with heart valve tissue with 24,48, and 72 hrs of C IT than in the control group of PHVF
cells cultured with fresh heart valve tissue, i.e. C IT = 0 hrs (P <0.05). In addition, AP
activities in PHVF cells that were cultured with heart valve tissue with 48, and 72 hrs
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Fig. 45: AP activities of the PHVF cells exposed to heart valve leaflet tissue sections
with zero and 24 hrs of in vitro warm ischemic time. 2x10s cells were seeded per 75
cm2 into a T-75 flask with alpha Minimum Essential Medium supplemented with 10%
FCS. The 0.2 grams heart valve tissue sections with zero and 24 hrs of warm ischemic
time (with 0 hr of C IT) were added to the culture flasks and cells were harvested for
analysis of AP activities when cells reached visual confluence.
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Fig. 46: AP activities in PHVF cells as a function of cold ischemic time of heart valve
tissue. 2X106 cells were seeded into 75 cm2 in a T-75 tissue flask with alpha Minimum
Essential Medium supplemented with 10% FCS. 0.2 grams heart valve leaflet tissue
sections with 24, 48, 72 hrs of cold ischemic time (with 0 hr of W IT) were added to the
culture flasks. AP activities were assayed on the day when cells reached confluence. The
error bars represent standard deviation.
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of C IT were significantly higher than PHVF cells sultured with H V tissue with 24 hrs
of C IT (P < 0.05).

Finally, it was of interest to know whether antibiotic treated heart valve tissue
could also induce AP activities in cultured PHVF cells. Heart valve tissue sections with
zero W IT and C IT (divided into 3 groups) were incubated in RPM I 1640 medium
supplemented with 10% FCS and amphotericin B, antibiotic solution A (amphotericin
B, lincomycin, vancomycin, cefoxitin, polymyxin B) or antibiotic solution B (lincomycin,
vancomycin, polymyxcin B, cefoxitin) for 24 hrs at 4°C. The concentrations of these
antibiotics are shown in Table 1. These antibiotic-treated heart valve tissue sections were
added to tissue culture flasks with PHVF cells (0.2 gram heart valve tissue per flask).
AP activities from the fibroblast cell cultures were assayed when

the PHVF cells

reached visual confluence. As is shown in Fig. 47, AP activities in amphotericin B,
antibiotic solution A treated groups were significantly higher than the control group (in
the presence of fresh heart valve tissue section which had been incubated in RPM I 1640
medium supplemented with 10% FCS at 4°C for 24 hrs) (P < 0.05). There were no
significant differences in AP activities between PHVF cell cultures exposed to heart valve
tissues incubated in RPM I 1640 medium supplemented with 10% FCS at 4°C for 24 hrs
and those incubated in antibiotic solution B at 4°C for 24 hrs (P > 0.0 5). Therefore, it
is suggested that amphotericin B was responsible for induction of high AP activities in
PHVF cells exposed to antibiotic solution A.
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It was possible that the residual antibiotics in the valve tissues might induce AP
activities in PHVF cells . Therefore, 2.5 ml of RPM I 1640 medium supplemented with
10% FCS and

amphotericin B, or antibiotic solution A, or antibiotic solution B

(concentrations shown in Table 1) were added to the culture flasks with PHVF cells
(seeding density was 2X106) in alpha Minimum Essential Medium supplemented with
10% FCS. AP activities were assayed when PHVF cells reached visual confluence. As
shown in Fig. 48, AP activities in all experimental groups (in the presence of 2.5 ml
various antibiotic solutions without heart valve tissue sections) were not significantly
different from the control group of porcine heart valve fibroblasts grown without adding
antibiotics or heart valve tissue (P > 0.05). Therefore, it is suggested that antibiotics
themselves do not induce AP activities in cultured PHVF cells.
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Fig. 47: Effects of antibiotic treated heart valve tissue on AP activities.

Group A:

control (addition of porcine heart valves which had been incubated in medium for 24
hrs). Group B: addition of porcine heart valves which had been incubated in RPMI
1640 medium supplemented with antibiotic solution B for 24 hrs (N = 6 ).

Group C:

addition of porcine heart valves which had been incubated in RPM I 1640 medium
supplemented with amphotericin B for 24 hrs (N = 8 ).

Group D: addition of porcine

heart valves which had been incubated in RPMI 1640 medium supplemented with
antibiotic solution A for 24 hrs (N = 6 ). 2X106 cells were seeded per 75 cm2 in a T-75
flask. AP activities were assayed on the day when PHVF cells reached confluence. The
error bars represent standard deviation.

Concentrations and compositions of the

antibiotics are shown in Table 1.
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Fig. 48: Effects of inclusion of various antibiotics in PHVF cultures on AP activities.
2X106 PHVF cells were seeded into a T-75 culture flask containing alpha Minimum
Essential Medium supplemented with 10% FCS. Group A served as a control culture
(PHVF cells only). Group B received the addition of 2.5 ml of amphotericin B to the
culture flasks.

Group C received the addition of 2.5 ml of antibiotic solution A to

culture flasks. Group D received the addition of 2.5 ml of antibiotic solution B to tissue
culture flasks (Concentration and compositions of these antibiotic solutions are shown in
Table 1).
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DISCUSSION

Allograft heart valves have been used for more than 25 years as a replacement
for diseased aortic valves and repair of congenital abnormalities. In many instances,
particularly pediatric surgery, it is the valve of choice due to its non-obstructive flow,
relative freedom from calcification and thromboembolism and that it does not require
anticoagulation therapy. Clinical studies, reported in the literature, indicate that aortic
allografts are excellent, especially for aortic valve replacements (Ross et al., 1979; Oyer
et al., 1980; Ionescu et al., 1977).

In consideration of other biological valves, the

allograft cardiac valves are thoroughly comparable.

In order to permit valve size

matching for recipients and reduce the potential for disease transmission, it is necessary
to find methods of storage which will maintain the physical, chemical and biological
properties of a valve. The best method which allows indefinite and convenient storage
is cryopreservation.

The longevity and durability of allograft heart valves has been suggested to be
dependent upon cellular viability because living fibroblasts are necessary for the
maintenance of the valve matrix (Lockey et al., 1972; Van der Kamp and Nauta, 1979).
This observation is supported by the fact that human aortic valves stored at 4°C for more
than 4 days have low viability at the time of transplantation and are non-vital at explant.
129
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Such valves have shown a significant increase in incidence of rupture and reduced leaflet
performance as well as a 20% to 30% increase in valve-related death, reoperation and
embolism when compared to vital cryopreserved allograft valves (O’Brien et al., 1987).
O’Brien et al., (1989) also reported 92% (± 2 ) of patients undergoing aortic valve
replacement with a viable homograft were free from all valve-related complications at
10 years after surgery, compared to 73 % (+ 4 ) of patients receiving a nonviable allograft
valve. In one instance, donor cells were cultured from a valve which had been explanted
after 9 years of functioning in a recipient.

In order to maintain cellular viability in a

cryopreserved valve, the highest standards of processing must be maintained throughout
the entire cryopreservation processing procedure.

Autoradiography, glucose metabolism, cell culture and histological studies have
been used to assess cellular viability of a variety of tissue types, and the present
investigation included

development

and

validation of an alternative method,

radiolabeled proline accumulation, to assess cellular viability.

Cellular viability is

defined as the ability of a cell or tissue to maintain itself and interact in a normal manner
with its environment and refers to a metabolic viability rather than reproductive viability.
The latter viability measures the capability of a cell population to increase in number.

Proline is transported across mammalian intestinal brush borders via the "imino
carrier" (Stevens and Wright, 1987).

The imino carrier is defined as an alanine-

insensitive, Na+-dependent proline transport system. The identity of the proline carrier
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has been established and reported to be a 100-kDa polypeptide (Wright and Peerce,
1984). The studies by Stevens and Wright (1987) suggested proline transport occurs by
a rapid equilibrium iso-ordered ter ter system. Two Na+ ions bind first to the carrier on
the cis face of the membrane to increase the affinity of the carrier for proline. The fully
loaded complex then isomerizes to release the substrates to the trans side. The partially
loaded Na+-only forms are unable to translocate across the membrane. A rate-limiting
step appears to be the isomerization of unloaded carrier from the trans to the cis side of
the membrane. It would be appropriate to suggest that fibroblast cells in heart valves
would contain a similar genome as brush-border cells and thus express a similar carrier
system for proline.

The transport / accumulation studies involving proline focused on estimating the
metabolic viability of the population of cells present in valve tissue. Justification for the
use of this imino acid includes the differential transport and accumulation of proline and
other amino acids, i.e., leucine, by the different cells types present in valve tissue. In
non collagen protein, the ratio of proline to leucine residues approximates 0.5, whereas
in collagen protein, this ratio typically exceeds 9.7 (Low et al., 1986). Low et al. (1986)
thus indicated that measurements of the percent of total protein synthesis devoted to
collagen are better measured with isotopic proline.

An excellent early study by van der Kamp and Nuata (1979) described the
accumulation and incorporation of radiolabeled proline and methionine into proteins by
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rat valve fibroblasts.

They clearly demonstrated by autoradiography that proline

represented an ideal amino acid for measuring synthesis of matrix proteins in these
valves, that proline incorporation was rapid (maximum at 3 hours) and that the
synthesized proteins were distributed through out the valve as a function of time. The
radiolabeled methionine was incorporated into cellular proteins more rapidly than proline,
but these radiolabeled proteins were quickly lost from the tissue. This autoradiographic
assay permits an assessment of viability of individual cells, but does not permit a
quantitative assessment of metabolic viability of the population of cells.

The data presented in

this study represented a different approach to a

demonstration that proline accumulation into the cellular component could be used to
assess cellular viability in the valve tissue.

Rather than concentrate on viability of

individual cells, the assay assessed metabolic viability of the population of cells. Data
presented clearly indicated that inulin accumulation by the heart valve leaflet tissue
sections was into extracellular space whereas proline accumulation was into both
extracellular and cellular space. That accumulation of proline as a function of time was
always greater than the accumulation of inulin clearly demonstrated that proline
accumulation in excess of inulin accumulation was attributable to cellular activity.
Trichloroacetic acid (TCA) has traditionally been used to precipitate proteins (Miozzo
et al., 1989; Cisneros and Dunlap, 1990; Beverly et al., 1991) and use of this reagent
to measure the incorporation of proline into protein by the heart valve tissue sections
permitted calculation of "pool" amino acids and "incorporated" amino acids at each time
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point. Heart valve tissue sections incorporated very little, i.e., less than 14%, of the
accumulated radiolabeled proline into protein over the three hours of the assay.

Calculation of the amounts of inulin and proline accumulated by cuspal tissue as
a function of the medium concentration of radiolabeled inulin and proline was also
informative. Linear accumulation of inulin and saturatable accumulation of proline as
a function of proline and inulin concentration in the transport medium further indicated
that the inulin accumulation is into the extracellular space of the tissue and proline
accumulation is into both the cellular and non-cellular component of the tissue. Tripathi
and Bhatnagar (1987) used ,4C-sucrose and ,4C-inulin to measure the extracellular fluid
space in rabbit SA node and atrial trabeculae. They found that ,4C-inulin is more reliable
marker for extracellular space than 14C-sucrose.

It was futher shown in this study that incubation of valve cuspal tissue in tissue
culture medium at 4°C resulted in loss of the ability of that tissue to accumulate
radiolabeled proline. If, as has been suggested (Hu et al., 1990), the loss of the ability
to accumulate proline was due to cell death, and that inulin accumulation does not depend
on cell viability, inulin accumulation should not be affected by tissue incubation at 4°C.
Data presented in this study support this suggestion and further support the hypothesis
that inulin accumulation is extracellular.
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Metabolic poisons such as dinitrophenol and sodium azide, are typically
uncouplers of oxidative phosphorylation.

In their presence, ATP synthesis does not

occur, yet substrate oxidation and oxygen consumption proceed maximally (Smith et al.,
1983). Dinitrophenol is a lipophilic weak acid that can migrate through the lipid phase
of the membrane in both the ionized and un-ionized form. Hence it "short-circuits" the
proton current by ferrying protons directly through the lipid phase of the membrane.
The toxic action of sodium azide relates primarily to its effects on mitochondrial
metabolism.

It uncouples oxidative phosphorylation and inhibits energy transfer

(Bogucka and Wojtezak, 1966; Palmieri and Klingenberg, 1967). In addition, it inhibits
the ATP-Pi exchange reaction and uncouples the first phosphorylation site (between
NADH and flavoprotein) (Bogucka aand Wojtezak, 1966).

Sodium azide and

dinitrophenol dramatically reduced proline accumulation, but not inulin accumulation by
valve leaflet tissue, and is further proof that proline and inulin accumulation permits a
calculation of the metabolic viability of the cellular component of the valve cuspal tissue.
Aortic, pulmonary, tricuspid, and mitral cuspal tissue accumulated an equivalent amount
of radiolabeled proline and inulin when the assay is normalized to mg tissue protein,
demonstrating that mitral and tricuspid valves make good candidates for use in cellular
viability assays since they are not generally used in valve replacement operations.

According to the data presented, it is suggested that radiolabeled proline and
inulin transport assays permit a quantitative estimate of total cellular metabolic viability
of heart valve tissues . The assay permits the evaluation of the effects of each step in
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the procurement, disinfection, cryopreservatiion, freezing, and thawing protocols on
retention of maximum cellular viability during valve cryopreservation. The quantifiable
bioassay provides researchers with the opportunity to alter conditions at each step in
order to minimize the loss of cellular metabolic viability in the cryopreservation of
cardiovascular tissue.

The present investigation described the time course of warm ischemic injury
occuring in valvular tissue using a porcine model. Proline accumulation dimished with
increasing time of ischemic injury. The basis for this reduction in proline accumulation
might be explained by the study by St.Louis et al. ( 1991). It was reported that after
approximately 2 hrs of in vitro warm ischemia , ATP is completely depleted, inorganic
phosphorus is no longer produced, and lactate begins to accumulate in significant
quantities.

These findings suggested that 2 hrs of ischemia results in cessation of

oxidative phosphorylation, a depletion of high-energy phosphate stores, and a conversion
to anaerobic metabolism.

This group also reported that following 24 hrs of warm

ischemia, increasing numbers of fibroblasts have undergone irreversible cellular injury,
as determined by morphologic study (St.Louis et al., 1991), and these data are consistent
with the absence of measurable proline transport by heart valve tissue with 24 hrs of
warm ischemic time.

The clinical results of O’Brien and his colleagues have suggested that
cryopreservation of human heart valve allografts following short ischemic times leads to
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prolonged valve durability following transplantation (O’Brien et al., 1988). The warm
ischemic injury data suggested that valves harvested in the prolonged cadaveric recovery
setting (24 hrs or more) would be expected to contain few viable cells. Leaflet fibroblast
cells in valves harvested between 2 and 24 hrs after donor death have depleted aerobic
metabolism yet contain numerous morphologically intact fibroblasts (St.Louis et al.,
1991). As demonstrated in this report, an accurate understanding of the time-dependent
effect of warm ischemia on leaflet cells, i.e. their potential viability, is necessary for the
construction of rational harvesting and preparation protocols.

It has been reported that cold ischemia reduces energy metabolism (Maessen et
al., 1988), and intracellular acidosis and depletion of ATP are features of hypothermic
storage (Buza et al., 1988). It has been suggested that the extent of lipid peroxidation
is significantly increased and oxidative damage occurs when CIT increases (Cotterill et
al., 1989).

As a result of such damage,

the function of different intracellular

membranes may be reduced. These membranes are, however, essential for the integrity
of the cells. Rao and Andrisevic (1988) reported that C IT had exerted an independent
adverse effect on graft functional survival of kidney transplants. Kumar et al. (1988)
also reported that late kidney graft function, up to 5 years, in kidneys with C IT of less
than 48 hrs is better than grafts with C IT of more than 48 hrs. Kumar’s group concluded
that long-term graft survival of human cadaveric kidneys preserved for longer than 48
hrs is significantly lower when compared with kidneys with shorter preservation periods
(Kumer et al., 1988). The present study also demonstrated that when CIT is shorter
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than 48 hrs, the heart valve leaflets stored in either Eagle’s M EM or UW solution were
able to accumulate as much as 40% of the proline accumulated by a "fresh" valve.
When C IT’s were longer than 48 hrs, the valves stored in Eagle’s M EM had almost no
ability to accumulate proline. These results of cold preservation of heart valve in vitro
are consistent with the clinical reports on kidney transplantation in vivo. It is suggested
that C IT should be shorter than 48 hrs during the procurement and processing in order
to have a vital tissue.

Development of the University of Wisconsin solution (UW ) was announced by
Jamieson et al. (1987) in 1987. This preservation solution has permitted significant
improvement in organ function after extended preservation of heart, kidney, liver, and
pancreatic tissues (Ploeg et al., 1988; Walberg et al., 1987). Maurer et al. (1990) have
demonstrated that UW solution preserved recovery of left ventricular function in hearts
at a more rapid rate with higher ATP content than other preservation solutions such as
modified Collins. Our study also demonstrated that following cold ischemic storage in
UW solution, the valve leaflets accumulate significantly more radiolabeled proline than
when the valve leaflets were stored in nutrient medium, such as Eagle’s M EM . In other
words, UW preserved heart valves exhibited higher cellular viability. The array of
substances in the UW solution addresses the theoretical challenges associated with
ischemic organ preservation. These include potassium to arrest the heart, phosphate for
buffering and magnesium sulfate as membrane stabilizer and metabolic inhibitor (Maurer
et al., 1990).

Adenosine in UW solution is included to stimulate ATP synthesis
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(Southard et al., 1985). During hypothermic preservation, sodium-potassium A TP^
activity is depressed.

Sodium and water enter the cell, and intracellular potassium

decreases. This loss of control of cellular water has been implicated as a primary cause
of unsuccessful heart preservation (Martin et al., 1972) and is probably primarily
responsible for loss of endothelial cells from the heart valve tissue. Glutathione reduces
cytotoxic agents, including hydrogen peroxide, lipid peroxides, ascorbate and free
radicals (Freeman and Crapo, 1982). Free radicals such as hydroxyl radicals are one of
the most damaging free radical metabolites formed during ischemia and reperfusion
(Menasche et al., 1987).

A ll these substances in the UW solution were probably

responsible for preservation of cellular viability in heart valve tissue as shown in this
study.

Since it is not generally practical to obtain valves under sterile conditions and
there is a high risk of contamination from postmortem bacterial growth, an efficient
method of sterilization is required. Various methods have been used to sterilize allograft
heart valves. In the past, ethylene oxide (Longmore et al., 1966), beta-propiolactone
(Rains et al., 1956), and gamma irradiation (Meeker and Gross, 1955), were used.
However, all of the above methods resulted in
damaged valves.

non-viable and possible structurally

Therefore, these methods are no longer used.

Today, the most commonly used and widely accepted method of disinfection for
allograft tissue is broad spectrum antibiotics in a nutrient medium. Antibiotic treatments
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should provide sterile tissue in a reproducible manner and simultaneously maintain
cellular viability.

The present study investigated the effectiveness of an antibiotic

solution (antibiotic solution A) previously used by LN-VTB. No viable bacteria were
present except for streptococcus faecalis after incubation of heart valve tissue in antibiotic
solution A for 24 hrs at 4°C. Gonzalez-Lavin studied 17 homovital aortic and pulmonary
valve conduits which were procured from hearts retrieved during sterile, multiorgan
harvests from brain-dead, heart beating cadavers and found that 9 allografts had positive
cultures (Gonzalez-Lavin et al., 1988c). A ll positive cultures were evident during the
first 48-h observation period. Contaminating organisms included anaerobic diptheroids,

S. aureus, andpropionibacterium. A ll fungal cultures were negative. Gonzalez-Lavin’s
study might suggest that streptococcus faecalis is not a common contaminant in heart
valve tissue.

Therefore, antibiotic solution A used by LN-VTB

effectively killed

common contaminating organisms in allograft heart valve.

In the present investigation, cellular metabolic viability of the valves following
incubation in RPMI 1640 medium supplemented with 10% fetal calf serum and different
antibiotic mixtures could be readily demonstrated in all fresh tissue examined. Incubation
of valves in amphotericin B for periods of time as short as 12 hrs resulted in a total loss
of cellular metabolic viability. Cefoxitin, lincomycin, polymyxin B and vancomycin have
no apparent effects on viability of cells. Streptomycin is also slightly toxic to the cells,
but not as toxic as amphotericin B. Penicillin is apparently not toxic to the cells.

139

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Studies by Aguirregoicoa’s group (1989) have also demonstrated, using trypan
blue dye exclusion assay, that amphotericin B was highly toxic to cultured aortic valve
fibroblasts.

In their study, the effect of amphotericin B at room temperature on the

viability of leaflet fibroblasts was rapid and highly detrimental. After only 4hrs at the
lowest amphotericin B concentration (5ug/ml), less than 50% o f the fibroblasts were
viable.

At the higher concentrations and longer time periods, residual viability was

negligible. Amphotericin B exhibited more toxicity at room temperature than at 4°C.
Antibiotic solution initially used to disinfect tissues was toxic due to the presence of
amphotericin B, but removal of this antibiotic from the disinfectant solution could result
in tissue containing fungal contamination. Aguirregoicoa’s group (1989) also suggested
that the fibroblast viability was hardly affected by nystatin. Lockey et al (1972) reported
that nystatin was more effective in antifugal activity than amphotericin B when used for
disinfecting contaminated heart valves.

The superior antifungal activity of nystatin and

lower toxicity against the aortic valve fibroblast cells, suggests that nystatin should be
substituted for amphotericin B in antibiotic solution if amphotericin B is omitted and
fungal contamination is a problem.

Amphotericin B is a broad spectrum antifungal agent that is active against
yeastlike fungi as well as dimorphic and filamentous fungi.

It exerts its effects by

disrupting cell membrane function in fungi and also binds to cholesterol of mammalian
cell membranes so that it is also toxic to mammalian cells (Craig et al., 1986). The
reduction in accumulation of proline by valves incubated in antibiotic medium containing
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amphotericin B is consistent with the observed disruption and damage to mammalian cell
membranes.

Streptomycin binds to the small ribosomal subunit (30 S) to inhibit protein
synthesis and results in bacterial cell death. Since the mammalian cells have a small
ribosomal subunit, the streptomycin may also bind to mammalian ribosomes to inhibit
protein synthesis (Craig et al., 1986; Pratt, 1977). It may therefore be suggested that
streptomycin reduces proline accumulation by the cells in the valve tissue by inhibition
of protein synthesis.

The results also suggest that streptomycin is not as toxic as

amphotericin B to the fibroblastic cells in heart valve tissues.

Polymyxin B interacts with the phospholipid components of cell membranes and
microbial toxicity is probably due to this interaction. At low concentrations, polymyxin
B exerts no gross effect on mammalian cells (Pratt, 1977) and the fact that the
concentration of polymyxin B used in our study was very low (lOOug/ml) may explain
the absence of cell toxicity by this antibiotic as suggested by the proline transport assays.

Penicillin prevents bacterial cell wall synthesis and in doing so kill bacteria. It
does not exert toxicity to mammalian cells since mammalian cells do not possess cell
walls.

In other words, it has selective toxicity. Our results are consistent in that

penicillin does not impair the cellular viability of valve leaflet tissue.

Cefoxitin and

vancomycin are also inhibitors of cell wall synthesis and presumably exert selective
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toxicity to bacteria. Penicillin, cefoxitin, lincomycin, polymyxin B and vancomycin do
not appear to affect cellular accumulation of proline, and cellular viability as assessed by
the proline accumulation procedure appears to correlate with known toxicities of
antibiotics towards mammalian cells.

Cryoprotectants (CPAs) are chemicals required for the viability of most
mammalian cells in the frozen state. There are two types of cryoprotectants: those that
diffuse across the biological membrane (permeating cryoprotectants, such as MeaSO and
glycerol, sucrose, propane diol) and those do not (the nonpermeating type, such as
polyvinylpyrrolidone,

dextran,

polyethylene

glycol,

hydroxyethyl

starch).

Cryoprotectants protect slowly frozen cells by one or more of the following mechanisms:
suppression of salt concentration; reduction of cell shrinkage at a given temperature; and
reduction in the fraction of the solution frozen at a given temperature.

It has been suggested that the toxicity of CPAs may be enhanced as
cryoprotectant concentration increases (Shlafer, 1981). Kim and Baldini (1986) incubated
platelets in 0.5%-5% glycerol at 22°C for 60 minutes and found that a loss in platelet
count was observed when the concentration of glycerol was more than 3%. They also
found a loss of 30% in cell count, a loss of 78% in aggregability when platelets were
exposed to 5% glycerol. Declining platelet response to hypotonic stress was shown with
1% glycerol and 69% of this function was suppressed by 5% glycerol. Platelet count,
aggregability and platelet response to hypotonic stress are the reliable indicators for
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viability of platelets. As reported in the present study, similar results were observed for
heart valve cells. Experiments involving constant times of incubation (10 minutes) and
variable concentrations of Me SO and glycerol revealed concentration dependent
2

toxicides. Incubation of valve leaflet tissue in both Me SO and glycerol concentrations
2

greater than 5 % resulted in a significant reduction in proline accumulation at both 4°C
and 37°C. The present findings indicate an inverse correlation between cellular viability
of heart valve tissue and concentrations of glycerol and Me^SO.

The cryoprotective effectiveness of permeable CPAs is dose dependent (Lovelock,
1954).

The proportion of cells that survive thawing increases with the CPA

concentration to a maximal value, then decreases as cumulative adverse effects are
manifested.

Lowering the duration of exposure of the nonfrozen system to a given

concentration reduces cryoprotectant toxicity, but may also reduce cryoprotective efficacy
(Karow, 1981). The data provided in this study revealed that when the time that heart
valve leaflet tissues were exposed to 10% (1.4M ) MezSO or 15% glycerol (2 M )
increased, proline accumulation by the tissue gradually decreased. However, lowering
the duration of exposure of tissue to Me^SO and glycerol, decreased toxicity of these
cryoprotectants, the efficacy of cryoprotective property of Me^SO and glycerol might
be also reduced because less MejSO and glycerol penetrated into the tissue. However,it
is critical that sufficient cryoprotectant penetrates into the tissue prior to freezing.

The

data revealed that it required 80 minutes for MejSO to maximally penetrate the tissue and
reach equilibrium and thus it was only half maximally penetrated into the tissue at 20
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minutes (approximately 0.3 M at 4°C and 0.4 M at 37°C).

The same situation is

applicable to glycerol. Glycerol permeated into the aortic conduit tissue maximally at
60 minutes. However, only half of the maximal concentration of glycerol entered the
tissue at 30 minutes. Proline accumulation by the tissue incubated in 15% glycerol was
also gradually reduced. Incubation of valve leaflet tissue in medium supplemented with
15% glycerol at either 4°C or 37°C, resulted in a significant reduction in subsequent
proline accumulation, i.e., approximately 40% reduction at 30 minutes and 60% at 60
minutes. Therefore, the concept that these two drugs, Me SO and glycerol, produce only
2

two major effects-cryoprotective and toxicity - is simplistic.

The fundamental

pharmacological concept that no drug produces only one effect is clearly applicable to
cryoprotectants.

It has been reported that at cryoprotective concentrations toxicity of permeable
CPAs may be attributable to either osmotic effects and / or effects of the cryoprotectants
on cell functions (Karow, 1991). Abrupt exposure of cells to high concentrations of
these CPAs initially cause osmotic loss of cellular water until osmotic equilibrium is
attained across the cell membrane.

It is difficult to distinguish the molecular

consequences of these two actions, or even to draw clear distinctions between them. The
present investigation revealed gradual osmolality reductions in the media when the
porcine aortic conduit tissue was exposed to 10% N ^S O and 15% glycerol over 100
minutes.

Future research should clarify that how much percentage of osmolality

reduction was due to water efflux from the tissue and how much was due to penetration
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of M ^SO and glycerol. Toxicides of these two cryoprotectants towards the heart valve
tissue might be due to effects of the cryoprotectants on cell functions as well as the
osmotic effects. Osmotic injury involves changes in covalent bonds and can persist for
long periods of time. The osmotic properties of permeable CPAs derive from the fact
that they are permeable to cells, however, they are not as permeable as water (Mazur and
Rajotte, 1981).

The chemical toxicity of CPAs is probably

attributable to the

observation that Me SO binds to protein (Clark et al., 1984), alters the functional
2

characteristics of mitocondria, and catalytic characteristics of Na+-K +-dependent ATP^
(Fuller et al., 1989), and catalase (Rammler, 1967). Me SO also alters tubulin assembly
2

and cytoskeletal integrity (Algaier and Himes, 1988). It relaxes vascular smooth muscle
and causes vasodilation, and it causes negative inotropic and negative chronotropic effects
on cardiac muscle (Shlafer and Garow, 1971). The toxicity of glycerol, however, has
been suggested to be mainly associated with its osmotic effect.

Alternatively,

the

concentration-dependent toxicity of glycerol has been suggested to be attributable to an
increased rate of release of some lysosomal enzymes (Dayian et al., 1971).

The

mechanisms of cryoprotectant toxicity described above might be attributable to the
observed reduction of proline accumulation by heart valve tissue in the present study.

The kinetics of M e^O and glycerol penetration into the aortic conduit was also
studied because it is critical that sufficient cryoprotectant penetrates into the tissue prior
to freezing.
possible.

Complete CPA equilibration within a tissue or an organ may not be

Segal and Guttman (1982) have reported that MejSO did not completely
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equilibrate with renal cortical or medullary tissues. This present study also demonstrated
that Me SO did not completely equilibrate within aortic conduit tissues when they were
2

incubated in 1.4 M MejSO and 2 M glycerol and these results are consistent with Segal
and Guttman’s study. They suggested that not all tissue water was available to M^SO.
"Bound water" unavailable to dissolved M e^O has been found in other tissue (Elford,
1970; Farrant, 1972).

Therefore, it is felt that these information could explain the

observations in the present study. Moreover, more glycerol penetrated into the aortic
conduit tissue (54% at 4°C and 65% at 37°C) than Me SO (46% at 4°C 61.5% at 37°C)
2

when the tissues were incubated in 10% Me SO (1.4 M ) and 15 % glycerol (2 M ). It has
2

generally been considered that glycerol diffusion across membrane is slower than that of
MejSO (Bank and Brockbank, 1987). However, this may not be the case with tissues
where cryoprotectants need not necessarily diffuse across cellular membranes to penetrate
the tissues. In fact, the rapidity of cellular influx of Me SO may be overstated. Bunch
2

and Edwards (1969) incubated barnacle muscle cells in 50 mM MeaSO (in a physiological
salt solution) at 30°C and obtained only 60% equilibration in these small cells after a 3
hr incubation. Menz (1976) and Menz and Fischer (1975) studied the distribution of
radiolabeled glycerol and MeaSO perfused through isolated rat hearts.

They

demonstrated an early, but brief (5 minutes), phase of rapid cryoprotectant equilibration
(tissue distribution), and indicated that initial kinetics did not differ appreciably for the
two agents. However, continued perfusion revealed a greater tissue loading for glycerol
that for MeaSO. Menz concluded that "glycerol can cross the capillary endothelium and
enter the myocardial cells as well as or better than M 2SO" (1976). The present results
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are consistent with Menz and Fischer’s observations, in that conduit tissue loading for
glycerol was greater than for Me SO. In addition, glycerol reached equilibrium in the
2

tissues faster (at 60 minutes) than Me SO (80 minutes). The present investigation studied
2

the time course of penetration of the cryoprotectants (Me SO and glycerol) into aortic
2

conduit tissue and this information greatly benefits the design of the cryopreservation
method.

Storage of cryopreserved tissue should be at a sufficiently low temperature so that
gradual growth of ice crystals through recrystallization over time is prevented. This
temperature of storage should be below the glass transition point of the medium in which
it is frozen in order to prevent chemical reactions. The glass transition temperature of
pure water is -139°C and freezing media are commonly in the range of -120°C.

In

general, temperatures in the -70°C to -115°C range are not suitable for the long-term
storage of viable tissues because of damaging ice crystal growth (recrystalization), as
well as physical and chemical reactions which can take place slowly with time (Bank and
Brockbank, 1987). To minimize such damage, Bank and Brockbank (1987) suggested
that samples should be stored in liquid nitrogen (-196°C) so that temperature fluctuations
do not occur during storage. The studies of the effects of heart valve submersion in
liquid nitrogen on cryopreserved human heart valves were performed during the course
of this research. The only difference between the valve tissue described in this study
is that the "experimental group" of valves were transiently submerged in liquid nitrogen.
This submersion mimics the conditions which might occur in the routine handling of
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cryopreserved tissues. Such tissues may be "accidentally" or intentionally submerged
into liquid nitrogen or transiently submerged for transport from one location to another.
Since the tissues are always at or below their glass transition point the variable is not the
cryopreservation process, but rather the abrupt changes in physical properties of the
solified matrix of the tissues.

Kroner and Luyet (1966) described abrupt temperature dependent changes in
aqueous glycerol solutions. They suggested that changes in the coefficient of expansion,
and in their correlatives, the density and specific volume, involve generation of stress.
Specifically, they reported that 97% glycerol solutions contracted by 2.8 cubic
millimeters/gram for every 10 degrees, above Tg (glass transition temperature) and by
0.4 cubic millimeter/gram below Tg.

They reported that when the temperature

approached -1 15°C, cracks developed in their specimens and the readings became erratic.
Subsequently, they reported (Kroner and Luyet, 1966) that the formation, and the
disappearance, of cracks depended on the interaction of several factors, in particular, the
mechanical properties of the material, the concentration of solutes, the temperature
gradients, the overall temperature, and the rate of temperature change. Specifically, at
cooling rates of 1 to 3 degrees Imin (temperature gradients of 6.5 to 8.5 degrees/cm)
cracks appeared. At higher cooling rates and larger gradients, the cracks disappeared
only at temperatures exceeding that of the glass transition (Kroner and Luyet, 1966).
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The appearance of cracks in the cuspal tissue of cryopreserved human heart valves
which experienced a sudden and dramatic change in temperature as a result of
submersion into liquid nitrogen are consistent with the observations of Kroener and Luyet
and it is

suggested that similar mechanisms are responsible for the cracks which

appeared in both systems (Adam et al., 1990; Wolfinbarger et al., 1991).

From a

practical standpoint, it is important to consider the potential for damage to cryopreserved
tissues which may result from the indescriminant movement of such tissue between the
vapor and liquid phase of liquid nitrogen. Storage of valves in liquid nitrogen would
tend to minimize temperature fluctuations during storage, but this advantage might be
negated by the problems associated with transfer of tissues in and out of liquid nitrogen
such as occur during transport. Storage of valves in the vapor phase of liquid nitrogen
introduces greater variability in temperature fluctuations, but valves may be more easily
transported in vapor phase and this advantage may outweight the disadvantages. In short,
provided valves are stored at temperatures below where recrystalization does not occur,
prevention of sudden and dramatic changes in temperature (and mechanical stress), may
be more important than the actual temperature of storage.

Heart valve allografts should be thawed at a rapid rate to enhance cell survival
(Ashwood-Smith and Farrant, 1980). Rapid warming serves to protect the cells that may
have any intracellular ice by limiting the amount of small ice recrystallization. Farrant
suggested that the injury to biological tissue associated with intracellular ice crystal
formation occurs primarily during the re-warming phase and not during the initial
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crystallization of cooling (Ashwood-Smith and Farrant, 1980). Not only is cell damage
seen during rewarming (as a function of ice recrystallization), but is has been suggested
that the melting of intracellular ice and resultant restoration of osmotic gradients may
also cause cellular injury.

It is generally accepted that thawing the frozen allograft in a 37°C to 42°C bath
will produce a rapid enough warming rate to inhibit macrorecrystallization and enhance
cell survival (Kirklin and Barratt-Boyes, 1986). As revealed in this study, when PHVF
cells were thawed by constant immersion in water maintained at temperatures of 37°C
and 42°C, the percentage of nonviable cells remained small.

Calculated thawing rates

were 60 and 75°C /minute, and cells were completely thawed in approximately 2.5 and
2 minutes, respectively, and only a relatively small percentage of the cells were dead.
When the thawing was performed in a water bath at 75°C, the thawing rate was much
faster (100°C / minute), and the percentage of dead cells were much higher than when
cells were thawed at 37°C and 42°C. Although rapid thawing rates can protect the cells
by limiting the amount of small ice recrystallization,

when the freezing medium is

warmed to a temperature very quickly, i.e., 100°C / minute and thawed, intracellular ice
may still be present. As a result, cells may be physically damaged by the ice or osmotic
swelling / shrinking which may physically rupture cells.

Slow warming of tissues exposes the cells to less osmotic shock because smaller
temperal osmotic gradients are experienced during warming, resulting in better cell
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viability in certain cell types, such as mammalian red blood cells (M iller et al., 1976)
and embryos (Whittingham et al., 1972). However, slow warming may favor ice crystal
recrystallization which may be harmful to cells.

In this study, slow thawing (warming

rates at 2.14°C / minute and 4.28°C /minute) caused much high percentages of cell death
than warming rates of 65°C / minute and 75°C /minute). These results suggest that too
slow warming rates may facilitate ice crystal recrystallization and result in PHVF cell
death. Whereas too rapid warming rates may generate osmotic stress and result in PHVF
cell death. Warming rates associated with thawing of cells in water baths at 37°C and
42°C appear to provide for optimal cell viability.

Immediately after thawing, a cell, tissue, or organ is surrounded by a solution of
essentially the same composition as that which surrounded it prior to freezing. The next
step was to transfer the cell or tissue to nutrient medium (isotonic) that lacks the
cryoprotectant. An abrupt transfer sets up an abrupt osmotic disequilibrium, since cells
are far more permeable to water than to these cryoprotectants. Osmotic equlibrium will
be restored primarily by the rapid movement of water. In other words, the cell will
undergo rapid osmotic swelling.

If the difference between the intracellular and

extracellular concentrations of cryoprotectant is great, the resulting swelling may be more
than the cells can tolerate.

The removal of cryoprotectants from thawed tissue is

optimally achieved by lowering the concentrations of external cryoprotectants in steps
that are sufficiently small and well separated in time so that the volume fluctuation of the
cell or tissue always remains within a tolerated range.
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The standard protocol that LN-VTB used to dilute the cryoprotectant (h^S O )
involves a dilution to 7.5% Me SO over 1 minute, followed by a dilution to 5% M ^SO
2

over 1 minute, followed by a third dilution to 2.5% Me SO over 1 minute. The allograft
2

is then transfered to a nutrient solution without M e^O . This step dilution procedure
presumably gradually decreases the osmolality of the solution in which the valve is held.
In this study, the concentrations of MezSO and glycerol in the aortic conduit tissue were
reduced approximately 30% (from 0.8 M to 0.6 M ) and 60% (from 1.2 M to 0.6 M ),
respectively, after three succesive one minute step dilutions. With continued incubation
in nutrient medium without cryoprotectants (1:10 dilution), the concentrations of Me SO
2

and glycerol were reduced to 0.25 M and 0.2 M respectively, after 40 minutes (at
equilibrium). These results suggest that the 1 minute allowed for each step dilution is
not adequate and that the concentrations of M ^SO and glycerol in the conduit tissue were
not effectively reduced. Theoretically, when the aortic conduit tissues were incubated
in nutrient medium without cryoprotectants (1:10 dilution), after the 3 succesive 1 minute
step dilutions, the concentrations of Me SO and glycerol in the conduit tissues should be
2

reduced from 0.6 M to 0.06M at equilibrium. What caused the higher concentrations
of MejSO and glycerol than expected in the conduit tissues at equilibrium is not quite
clear. One possibility is that these two cryoprotectants might tightly bind to the tissue.

The second part of the study, associated with the propensity of implanted allograft
heart valves to calcify, derives primarily from studies of mineralization of deminerilized
bone (DMB) following implantation. The osteoinductivity of DMB has long been the
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subject of research assessing ectopic bone formation in animals (Urist, 1965; Reddi and
Huggins, 1973). Beginning in the early 1980s, researchers began to study in vitro cell
culture systems as a means of assessing the osteoinductivity of DMB and other substances
using a variety of fibroblast cell lines.

It has been reported that mouse embryonic

fibroblast cells have been successfully induced to differentiate into osteoblastic cells by
recombinant human bone morphogenic protein (Katagiri et al., 1990; Reddi and Huggins,
1973).

Therefore, it is postulated that DMB has osteoinductivity, and this

osteoinductivity would stimulate mesenchymal cells to differentiate into osteogenic cells.
Covey et al., (1989) defined osteoinduction as the process of new bone formation from
osteoprogenitor cells derived from fibroblast-like migratory mesenchymal cells under the
influence of two factors: (1) a chemotactic-like factor that attracts blood vessels as well
as mesenchymal (such as fibroblast cells) and osteoprogenitor (if implanted in bony
tissue) cells from the immediate vicinity; (2) a factor such as bone morphogenic protein
(BMP) that induces mesenchymal and progenitor cells to transform into osteogenic cells.
The osteoinductive sequence of events includes phenotypic conversion of connective
tissue into cartilage, which becomes calcified, invasion by host vessels, and replacement
by bone.

Alkaline phosphatase (AP) activity is a very important early marker of osteogenic
cells.

High AP activity was detected in condensed mesenchemal cells prior to the

increase of type I collagen synthesis and osteoid or mineral deposition (Zemik et al.,
1990). High AP activity is a property shared by all osteo-inducing cells but not by
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nonosteoinductive cells such as fibroblast cells (Wlodarski and Reddi, 1986). Many
classical works on osteogenesis have used AP activity as a characteristic o f osteogenic
expression and it has been reported that the AP activity of cultured human osteoblastic
cells is 3.3 times higher than the AP activity of cultured human fibroblastic cells
(Koshihara et al., 1989). AP hydrolyzes phosphoesters to facilitate mineralization by
several possible mechanisms, including increasing regional phosphate concentrations, thus
elevating calcium and phosphate product at potential initial calcification sites and
degradation of endogenous inhibitors of calcification, such as pyrophosphate and
phosphocitrate (Anderson, 1989).

In this study, a porcine heart valve fibroblast cell line was used to demonstrate
the osteoinductivity of variously processed heart valve tissue. It. is suggested that this
approach may represent a rather unique way of assessing the potential of cardiovascular
and perhaps other, tissues to calcify following transplantation. Wheatley and associates
(1977) found that the cells cultured from allograft valves explanted at 1, 4, and 8 weeks
in an experimental dog model had both host and donor chromosomes. These results
suggest that implanted allograft valves were infiltrated with recipient’s fibroblasts or
other connective tissue cells. Gonzalez-Lavin and his colleagues recently also reported,
using cytogenetic analysis, that host fibroblast cells repopulated the inner one-third of
the implanted donor valve leaflets (Gonzalez-Lavin et al., 1990). If heart valve tissue
has osteoinductive activity, according to the hypothesis of osteoinduction, fibroblast cells
would be stimulated to differentiate into osteogenic cells upon exposure to heart valve
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tissue, and the AP activity should be significantly increased, perhaps to those levels
expressed by osteogenic cells.

A part of the work presented in this dissertation included an assessment of
osteoinductivity by variously processed porcine heart valve tissue, including varied W IT,
CIT, and treatment with antibiotics.

Data from this study might be important in

assessing the propensity of heart valves to calcify following transplantation. The present
study clearly revealed prolonged W IT, C IT and post-amphotericin B treated heart valves
induced higher AP activities in porcine fibroblast cells .

As presented early in this dissertation, heart valve tissue with increased W IT,
CIT, and post-amphotericin B treatment resulted in reductions of proline accumulation,
i.e., loss of cellular viability in the heart valve tissue. Jeong successfully demonstrated
less calcification and better function following transplantation of viable homograft valves
(Jeong et al., 1976). It is suggested, based on results presented in this present study, that
a factor contributing to calcification of implanted valves may be the infiltration of host
fibroblast cells into the implanted valves where "factors" or "substances" in the donor
valves may induce the host fibroblast cells to undergo differentiation to osteoblast-like
cells which may ultimately result in calcification of the implanted valves through elevated
levels of alkaline phosphatase.
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Based on information derived from tins study, and research by other groups, the
following points should be considered as important to allograft heart valve calcification
following transplantation. Proteoglycans are soluble molecules which may be easily lost
from the matrix of valves (Campo and Ramano, 1986).

Enzymatic degradation of

proteoglycans facilitate this loss as well as altering the capacity of proteoglycans to bind
calcium ions (Hunter, 1991). Death of fibroblastic cells in heart valve tissue during
procurement and processing will release hydrolytic enzymes into the matrix space of the
tissue, resulting in proteoglycan and collagen degradation.

Degradation products of

proteoglycans and collagen would easily diffuse from the valve tissue into adjacent tissues
o f the valve transplanted recipient and this "gradient" of degradation products might
serve to attract host mesenchymal (fibroblastic) cells and macrophages into the donor
tissue. The ablity of this donor tissue to stimulate fibroblastic cells to differentiate into
osteoblast-like cells would result in an increase in levels of alkaline phosphatase. This
enzyme has been shown to be associated with the mineralization process as described
previously, presumably through increases in inorganic phosphate concentrations which
may associate with elevated calcium levels (which occur because less proteoglycan is
available to chelate with free calcium ion).

Matrix vesicles (or plasma membrane

fragments from dead cells) would presumably serve as nucleation sites for calcium and
phosphate crystallization.

Another possible reason of valve tissue with no viability or reduced viability to
induce higher AP activities in vitro and calcification in vivo is possible presence of "bone
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morphogenic protein" or bone morphogenic protein-like substance in heart valve tissue.
Bone morphogenic protein has been shown to have the ability to induce AP activities in

vitro and bone formation in vivo (Katagiri et al., 1990). Bone morphogenic protein is
a group of glycoproteins that was originally found in the acid-insoluble proteins extracted
from acid-demineralized bone matrix (Urist et al., 1976).

In normal physiological

conditions, usually in the neutral pH range, bone morphogenic protein is thought to be
degraded by an endogenous bone morphogenic proteinase that functions at neutral pH and
temperatures between 37°C and 40°C (Hirano and Urist, 1991). In acidic conditions,
such as occurs during the acid demineralized process used to demineralize bone, bone
morphogenic proteinase is degraded and bone morphogenic protein is activated. As we
know, acidosis is very common when cells die, and since bone morphogenic protein is
acid-insoluble, this protein would presumably be activated after cell death. Therefore,
"bone morphogenic protein" or "bone morphogenic protein-like" substance present in
heart valves may be responsible for the induction of higher AP activities.
Demonstration of the presence of "bone morphogenic protein" or "bone morphogenic
protein-like" substance in heart valve tissue would strongly support this suggestion and
future studies focusing on this subject would clarify this issue.

The evidence presented in this study suggests that PHVF cells cultured with
variously processed heart valve tissue, might differentiate into osteogenic cells.
However, it is not clear whether the PHVF cells differentiate into osteoblasts,
osteoprogenitor cells, or some other stage of the differentiation process. Analyses for
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specific cellular markers (e.g., osteocalcin and type I collagen) in future studies will help
to clarify this issue.

This information may help to explain a possibly mechanism

contributing to allograft heart valve calcification after transplantation.

This assay

measures only one of several steps which are presumably involved in calcification and
induction of AP activity is not "calcification", but rather is only one of several events
involved in calcification.

Based on the results presented in this study, the following points can be
concluded:

(1). The present study has clearly demonstrated that radiolabeled proline accumulation
provides a quantitative and reliable estimate of cellular metabolic viability in heart
valve tissue.

(2). Duration of in vitro warm and in vitro cold ischemia experienced during
procurement and transportation of heart valve tissue affect cellullar metabolic
viability in heart valve tissue. Proline accumulation declined with increasing in

vitro warm ischemic time and in vitro cold ischemic time.

(3). Both amphotericin B and streptomycin were toxic to the cells of heart valve tissue.
Antibiotic solution (amphotericin B, cefoxitin, polymyxin B, lincomycin,
vancomycin) utilized to disinfect tissue was able to kill E. coli, S. aureus, S.

158

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

epidermidis, S. pneumoniae, C. perfringens but not S. faecalis. This observation
strongly suggests this antibiotic solution effectively killed the common
contaminating organisms in allograft heart valve.

(4). The cryoprotectants, MezSO and glycerol reduced cellular metabolic viability when
heart valve leaflets were incubated in RPMI 1640 medium supplemented with
10% Me SO or 15% glycerol over 180 minutes at both 4°C and 37°C.
2

An

inverse correlation between cellular viability of heart valve tissue and
concentrations of glycerol and

was found.

Penetration rates of both

MeaSO and glycerol at 37°C were faster than that at 4°C.

After equilibrium,

more glycerol was taken into the aortic conduit tissue than MeaSO.
Understanding the time course of penetration of the cryoprotectants into tissues
prior to freezing would greatly benifit the design of the cryopreservation
protocols. Selection of appropriate concentrations of cryoprotectants and time of
exposure to cryoprotectants are also very important.

(5). The cryopreserved human heart valve tissue plunged into liquid nitrogen resulted in
numerous microfactures over the surfaces of the tissue, penetrating the collagen
/ proteoglycan matrix.

Storage of allograft heart valve below -135°C and

avoidance of sudden changes of temperature and mechanical impact are strongly
recommended.
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(6). Rapid thawing (at 37°C and 42°C) resulted in lower percentages of nonviable cells.
Current protocol used to dilute the cryoprotectants is not effective in removing
all Me SO or glycerol from the allograft tissue prior to transplantation.
2

(7). Heart valves with prolonged warm ischemic time, cold ischemic time and postamphotericin B treatment, i.e., factors reducing cellular metabolic viability,
induced significantly higher AP activities in porcine fibroblast cells, implying
these valves might be more likely to calcify after implantation.

(8). Based on the information presented in this study, and from other studies, it is
suggested that retention of a viable cell population in cryopreserved heart valves
may be more important in reducing the tendency of the valve to calcify following
transplantation than in providing a cell population capable of maintaining the
matrix structure of the valve. Hydrolytic enzymes released from dead and / or
dying cells could significantly degrade matrix molecules in the valve enhancing
their diffusion from the transplanted valve.

Allograft heart valves have a number of advantages over non-viable allografts and
alternate valves. Although allograft heart valve have been used clinically for nearly 25
years, very few in-depth studies have been undertaken to evaluate and understand this
method of allograft heart valve cryopreservation. The present investigation has evaluated
each step of the protocols on the physical, biochemical, and cellular aspects of heart
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valve tissue. Optimization of the cryopreservation procedure is now possible. This study
has helped to change the method of cryopreservation of heart valves which will
eventually yield even better allograft valves with greater durability and longevity which
w ill ultimately benefit the patient.
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